<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Surgical management of stress urinary incontinence in females: Retropubic midurethral slings</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Surgical management of stress urinary incontinence in females: Retropubic midurethral slings</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Surgical management of stress urinary incontinence in females: Retropubic midurethral slings</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles W Nager, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jasmine Tan-Kim, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Linda Brubaker, MD, FACOG</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 04, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H25744271"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>SUI occurs when an increase in intraabdominal pressure exceeds urethral closure pressure, resulting in the involuntary leakage of urine. This may occur with exertion, sneezing, or coughing [<a href="#rid1">1</a>]. Stress urinary incontinence (SUI) affects 4 to 35 percent of women [<a href="#rid2">2,3</a>]. Management options for SUI include conservative and surgical treatments.  </p><p>Retropubic midurethral sling (MUS) procedures are reviewed here. Transobturator midurethral slings and the approach to choosing a procedure for SUI in women are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/14218.html" rel="external">"Surgical management of stress urinary incontinence in females: Transobturator midurethral slings"</a> and  <a class="medical medical_review" href="/z/d/html/8070.html" rel="external">"Female stress urinary incontinence: Choosing a primary surgical procedure"</a> and  <a class="medical medical_review" href="/z/d/html/15908.html" rel="external">"Surgical management of stress urinary incontinence in females: Choosing a type of midurethral sling"</a>.)</p><p>In this topic, when discussing study results, we will use the terms "woman/en" or "patient(s)" as they are used in the studies presented. We encourage the reader to consider the specific counseling and treatment needs of transgender and gender diverse individuals.</p><p class="headingAnchor" id="H1168793"><span class="h1">TERMINOLOGY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Procedure history</strong> – Midurethral sling (MUS) placement has replaced other procedures (eg, retropubic colposuspension, pubovaginal slings) as the procedure of choice for many women [<a href="#rid4">4,5</a>]. The tension-free vaginal tape (TVT), introduced by Ulmsten in 1996, was the first synthetic retropubic midurethral sling [<a href="#rid6">6</a>]. Since that time, variations of retropubic midurethral slings as well as midurethral transobturator slings have been introduced.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Standardized terminology</strong> – The terminology for surgical procedures to treat stress urinary incontinence in women has been standardized in a joint publication by the American Urogynecologic Society and the International Urogynecological Association, and those terms will be used in this document [<a href="#rid7">7</a>]. There are two main l types of sling procedures for treatment of SUI in women: midurethral slings and pubovaginal slings  (<a class="graphic graphic_table graphicRef98504" href="/z/d/graphic/98504.html" rel="external">table 1</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Midurethral sling</strong> – A midurethral sling is a vaginal surgery involving tension-free placement of a type 1 polypropylene mesh strip, or tape, between the vagina and the urethra near its midpoint. Words delineating the path (retropubic or transobturator) and direction of the trocars or the number of incisions can be used to more specifically describe the procedure [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Retropubic midurethral slings</strong> are most commonly performed by passing a trocar retropubically from the vagina on each side of the urethra through the retropubic space and exit through the abdominal wall and skin in the suprapubic area bottom-to-top  (<a class="graphic graphic_figure graphicRef59114" href="/z/d/graphic/59114.html" rel="external">figure 1</a>) or they are inserted starting at the abdominal wall and exit under the midurethra (top-to-bottom).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Transobturator midurethral slings</strong> are inserted in-to-out through the vaginal incision, through the obturator foramen and exit through the skin of the groin area  (<a class="graphic graphic_figure graphicRef52240" href="/z/d/graphic/52240.html" rel="external">figure 2</a>) or they are inserted out-to-in through the groin incision, through the obturator foramen and exiting the vaginal suburethral incision.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Single incision or adjustable midurethral slings </strong>differ from full-length retropubic and transobturator slings in two ways: they are shorter (approximately 8 cm rather than 40 cm) and they require only a vaginal incision, and not an abdominal or groin incision. Different types of these slings may be placed in a retropubic (anchored to the urogenital diaphragm) or transobturator fashion (anchored to the obturator internus muscle).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pubovaginal </strong>is an abdominovaginal surgery that uses a length of fascia, tissue, or graft to support the urethra with an abdominal wall fixation site  (<a class="graphic graphic_figure graphicRef76965" href="/z/d/graphic/76965.html" rel="external">figure 3</a>). The sling material is most commonly autologous and thus, the procedure has been referred to as a "fascial" sling; specifically, fascia from the rectus sheath or fascia lata has been used, but other materials (including allogenic, xenogenic, or synthetic grafts) have been described with varying success rates and complications [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/14216.html" rel="external">"Surgical management of stress urinary incontinence in females: Pubovaginal sling procedures"</a>.)</p><p></p><p class="headingAnchor" id="H2819310"><span class="h1">MECHANISM OF ACTION</span><span class="headingEndMark"> — </span>Midurethral sling placement involves the introduction of a polypropylene tape (approximately 1 cm in width) covered in a plastic sheath beneath the midportion of the urethra. This sling functions as a backboard that offers resistance beneath the urethra during increases in intraabdominal pressure, but is tension-free at rest. Ultrasound data suggest that continence is achieved by compression of the urethra between the sling and the pubic symphysis [<a href="#rid8">8-10</a>]. </p><p>For retropubic midurethral slings, the tails of the mesh pass through the retropubic space, rectus sheath, subcutaneous tissue and skin  (<a class="graphic graphic_figure graphicRef59114" href="/z/d/graphic/59114.html" rel="external">figure 1</a>). Once the plastic sheaths are removed, the tape is held in place by its interface with the patient's tissue; it is not held in place by sutures. The friction that initially secures the mesh is eventually reinforced with tissue fibrosis develops around and through the mesh. Porcine models demonstrate that 74 percent of the final strength has already been achieved by two weeks postoperatively and maximum strength of tissue in-growth into polypropylene mesh occurs at three months [<a href="#rid11">11</a>]. </p><p class="headingAnchor" id="H25744285"><span class="h1">SURGICAL CANDIDATES</span></p><p class="headingAnchor" id="H3791434"><span class="h2">Indications</span><span class="headingEndMark"> — </span>Indications for midurethral sling placement are:</p><p class="bulletIndent1"><span class="glyph">●</span>Symptomatic SUI or stress-dominant mixed incontinence</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Women who are planning repair of prolapse of the vaginal apex and who have known or suspected occult SUI</p><p></p><p>Symptomatic SUI may be treated with conservative measures (pelvic floor muscle training, incontinence pessaries), urethral bulking agents, or a surgical approach. Candidates for surgical treatment are women with SUI who decline or have had unsuccessful conservative treatment. (See  <a class="medical medical_review" href="/z/d/html/8070.html" rel="external">"Female stress urinary incontinence: Choosing a primary surgical procedure", section on 'Candidates for surgical treatment'</a>.)</p><p>Advanced pelvic organ prolapse and SUI commonly co-exist; however, in many women, the SUI becomes apparent only when the prolapse has been corrected. This phenomenon is known as occult SUI. Preoperative prolapse reduction stress testing with or without urodynamics can suggest, but unfortunately cannot completely predict, occult stress incontinence. Concomitant anti-incontinence surgery can be offered to women who are undergoing repair for advanced pelvic organ prolapse. This topic is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/8068.html" rel="external">"Pelvic organ prolapse and stress urinary incontinence in females: Surgical treatment", section on 'Symptomatic POP without symptomatic SUI'</a>.)</p><p class="headingAnchor" id="H3793143"><span class="h2">Additional characteristics for consideration</span><span class="headingEndMark"> — </span>Evaluating whether an individual with SUI is an appropriate candidate for surgical treatment, and a midurethral sling in particular, may depend upon additional factors, including:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urinary function issues</strong> (eg, intrinsic sphincter deficiency, lack of urethral hypermobility, mixed incontinence, voiding dysfunction) – </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intrinsic sphincteric deficiency (ISD)</strong> – Data are fairly consistent that women with ISD (defined as maximal urethral closure pressure &lt;20 cm H<sub>2</sub>O or Valsalva leak point pressure &lt;60 cm H<sub>2</sub>O) have worse surgical outcomes than overall SUI patients. Overall cure rates in women with ISD tend to be lower with objective and subjective cure rates of 52.1 and 47.9 percent compared with all SUI 88.2 to 85.9 percent [<a href="#rid12">12</a>]. </p><p></p><p class="bulletIndent1">While historically the pubovaginal autologous fascial sling was the preferred treatment for intrinsic sphincter deficiency, the overall safety and efficacy of the midurethral sling has changed this paradigm. In a large randomized trial of 597 women with SUI undergoing either retropubic midurethral sling or a transobturator midurethral sling, lower quartile Valsalva leak point pressures, and lower quartile maximum urethral closure pressures conferred an almost twofold increased odds of objective failure regardless of sling route [<a href="#rid13">13</a>]. Other studies suggest that women with ISD may be better served with a retropubic midurethral sling rather than a transobturator sling. In a 2016 systematic review and meta-analysis comparing the efficacy of the retropubic midurethral sling with the transobturator midurethral sling, the retropubic approach resulted in a 10 percent higher subjective cure rate in patients defined to have ISD [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obesity </strong>– (See  <a class="medical medical_review" href="/z/d/html/8070.html" rel="external">"Female stress urinary incontinence: Choosing a primary surgical procedure", section on 'Obese women'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Increasing age and/or frailty</strong> – (See  <a class="medical medical_review" href="/z/d/html/8070.html" rel="external">"Female stress urinary incontinence: Choosing a primary surgical procedure", section on 'Older, frail, or medically complex individuals'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Concomitant procedures</strong> – Many women undergo anti-incontinence surgery concomitantly with other procedures (eg, pelvic organ prolapse repair, hysterectomy). Most data suggest that concomitant surgery does not decrease midurethral sling success rates. (See  <a class="medical medical_review" href="/z/d/html/8070.html" rel="external">"Female stress urinary incontinence: Choosing a primary surgical procedure", section on 'Coexistent anatomic or functional abnormality'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Previous anti-incontinence surgery</strong> – Many cases of unsuccessful previous stress incontinence surgery can be effectively treated with retropubic midurethral sling. Documented cure rates of 70 to 90 percent for the TVT as a secondary procedure have been shown with one to five years of follow-up [<a href="#rid15">15-18</a>]. (See  <a class="medical medical_review" href="/z/d/html/8078.html" rel="external">"Stress urinary incontinence in females: Persistent/recurrent symptoms after surgical treatment", section on 'Midurethral sling'</a>.) </p><p></p><p class="headingAnchor" id="H299273"><span class="h2">Contraindications</span><span class="headingEndMark"> — </span>Contraindications to midurethral retropubic sling placement include:</p><p class="bulletIndent1"><span class="glyph">●</span>Current urinary tract infection</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Current pregnancy</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anticoagulation</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Structures in the retropubic space that are in the path of sling placement (eg, vascular graft, bowel, transplanted pelvic kidney)</p><p></p><p>Current pregnancy is an absolute contraindication to midurethral sling placement. Plans for future pregnancy are a relative contraindication. Since pelvic support may be disrupted during pregnancy, and particularly following a vaginal birth, most physicians recommend delaying surgical management of SUI until childbearing has been completed. (See <a class="local">'Subsequent pregnancy'</a> below.)</p><p>The procedure is relatively contraindicated in patients who are anticoagulated. Midurethral sling placement involves passing trocars through several tissue layers and may result in hematoma formation or hemorrhage. The risk of hematoma formation is probably more with retropubic approaches than with transobturator approaches, so women with bleeding diatheses (eg, Von Willebrand's) may be better served with administration of preoperative control measures (eg, <a class="drug drug_general" data-topicid="9330" href="/z/d/drug information/9330.html" rel="external">desmopressin</a>) and a transobturator approach.</p><p>Certain conditions or previous retropubic surgery may predispose to complications during sling placement. Previous retropubic surgery may have resulted in the presence of bowel in the retropubic space or an inguinal or abdominal hernia sac may be located along the pathway of trocar placement [<a href="#rid19">19</a>]. Likewise, a transplanted kidney [<a href="#rid20">20,21</a>] or femoral crossover graft may be in the insertion path of the sling. </p><p>For women in whom there are concerns that the retropubic space could contain bowel or other structures (eg, a vascular graft, transplanted kidney, inguinal hernia) based upon previous operative procedures or findings, or imaging studies, we suggest a transobturator approach. The retropubic and transobturator approaches have been shown to have comparable efficacy in randomized trials. (See  <a class="medical medical_review" href="/z/d/html/15908.html" rel="external">"Surgical management of stress urinary incontinence in females: Choosing a type of midurethral sling", section on 'SUI background and treatment options'</a>.)</p><p>Some physicians will choose a transobturator route to avoid a scarred retropubic space in women who have had a previous Burch colposuspension, pubovaginal sling procedure, or midurethral sling, but a prior history of any of these procedures is not a contraindication to placement of a midurethral sling [<a href="#rid15">15</a>]. Treatment of recurrent SUI is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/8078.html" rel="external">"Stress urinary incontinence in females: Persistent/recurrent symptoms after surgical treatment", section on 'Midurethral sling'</a>.)</p><p class="headingAnchor" id="H2819431"><span class="h1">COMPARISON OF INSERTION ROUTES</span><span class="headingEndMark"> — </span>There are two main variations of full-length retropubic midurethral slings, based upon the initial incision site and direction of insertion:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bottom-to-top</strong> – Two needle trocars are inserted through a vaginal incision and passed through the retropubic space, exiting at the abdominal wall.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Top-to-bottom</strong> – Two needle trocars are inserted through abdominal incisions and passed through the retropubic space, exiting through a vaginal incision. </p><p></p><p>The bottom-to-top approach appears to be superior. A meta-analysis of five randomized trials, including a total of 636 women, compared bottom-to-top (TVT) and top-to-bottom (SPARC) procedures [<a href="#rid22">22</a>]. The TVT was slightly more effective; at up to one-year follow-up, the TVT group had higher subjective cure rates (85 versus 77 percent, RR 1.10, 95% CI 1.01-1.20) and objective cure rates (92 versus 87 percent, RR 1.06, 95% CI 1.01-1.11). In addition, complications occurred less frequently in the TVT group, including bladder perforation (4.7 versus 8.5 percent, RR 0.55, 95% CI 0.31-0.98); vaginal mesh erosion (0.7 versus 3.5 percent, RR 0.27, 95% CI 0.08-0.95); and voiding dysfunction (2.2 versus 6.0 percent, RR 0.40, 95% CI 0.18-0.90). Some surgeons feel more comfortable with top-to-bottom insertion because they are familiar with this approach because of historical needle suspension procedures. However, given these data, we suggest use of the bottom-to-top approach.</p><p>Choosing between retropubic, transobturator, and single incision midurethral slings is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/15908.html" rel="external">"Surgical management of stress urinary incontinence in females: Choosing a type of midurethral sling"</a>.)</p><p class="headingAnchor" id="H297922"><span class="h1">PREOPERATIVE EVALUATION AND PREPARATION</span></p><p class="headingAnchor" id="H298913"><span class="h2">Informed consent</span><span class="headingEndMark"> — </span>Treatment options for symptomatic SUI should be reviewed with the patient. Surgeons should discuss the efficacy of the procedure, the placement of permanent mesh, and the risk of complications (eg, voiding dysfunction). Patients should be counseled that midurethral sling placement is not intended to treat urinary urgency, frequency, or nocturia, and that resolution of these symptoms should not be expected [<a href="#rid23">23-25</a>], although some overactive bladder symptoms may improve after midurethral sling placement [<a href="#rid26">26</a>]. In a large, well-characterized, randomized trial, mixed incontinence patients receiving a midurethral sling experienced a 75 percent reduction in urogenital distress inventory irritative scores and only 2 percent of participants experienced worsening urgency [<a href="#rid27">27</a>]. (See <a class="local">'Complications'</a> below.) </p><p>For women with known or suspected occult SUI, the option of a staged or concomitant procedure and the potential for unnecessary surgery should be discussed. </p><p>This discussion should be documented on the surgical consent form and in the medical record.</p><p class="headingAnchor" id="H297972"><span class="h2">Evaluation</span><span class="headingEndMark"> — </span>Women who are planning midurethral retropubic sling placement should undergo preoperative evaluation to confirm the diagnosis of SUI, exclude other etiologies of urinary incontinence, confirm normal bladder emptying, and assess surgical risk. </p><p>Components of this evaluation include:</p><p class="bulletIndent1"><span class="glyph">●</span>Medical and voiding history</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pelvic examination </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Office urinary function testing to demonstrate stress leakage and normal bladder emptying (eg, urinary stress test, postvoid residual volume)</p><p></p><p>Current evidence does not require urodynamic testing in all women prior to surgery. We suggest that preoperative urodynamics be performed only in women with complicated SUI (eg, previous anti-incontinence surgery, neurogenic lower urinary tract dysfunction, or suspicion of a nonstress etiology of urinary incontinence) or when stress leakage cannot be demonstrated or when symptoms are not consistent with physical examination findings. </p><p>Preoperative evaluation of women with SUI is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/8088.html" rel="external">"Surgical management of stress urinary incontinence in females: Preoperative evaluation for a primary procedure"</a>.)</p><p class="headingAnchor" id="H297929"><span class="h2">Antibiotic prophylaxis</span><span class="headingEndMark"> — </span>We recommend antibiotic prophylaxis for surgical site infection for procedures for treatment of pelvic organ prolapse or SUI that utilize surgical mesh, such as midurethral sling placement. Infectious complications of such procedures include infections associated with the surgical mesh (eg, abscess, cellulitis) and urinary tract infections, particularly for procedures that involve periurethral dissection [<a href="#rid28">28-33</a>]. </p><p>Our recommendation is in concert with professional society guidelines. American College of Obstetricians and Gynecologists guidelines advise antibiotic prophylaxis for surgical site infection for urogynecologic procedures, including those with vaginal mesh [<a href="#rid34">34</a>]. American Urological Association guidelines also advise use of antibiotic prophylaxis for all patients undergoing open or laparoscopic procedures involving an implanted prosthesis [<a href="#rid35">35</a>].</p><p>Use of surgical mesh does not affect the need for antibiotic prophylaxis of bacterial endocarditis. </p><p class="headingAnchor" id="H297936"><span class="h2">Thromboprophylaxis</span><span class="headingEndMark"> — </span>Midurethral sling placement is minor surgery (defined as &lt;30 minutes) and is typically performed in mobile patients. Thus, those patients who have no additional thrombotic risk factors are classified as low risk for venous thromboembolism and do not require specific thromboprophylaxis. (See  <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">"Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"</a> and  <a class="medical medical_review" href="/z/d/html/3301.html" rel="external">"Overview of preoperative evaluation and preparation for gynecologic surgery", section on 'Thromboprophylaxis'</a>.)</p><p class="headingAnchor" id="H25744362"><span class="h1">PROCEDURE</span><span class="headingEndMark"> — </span>In this section, we will describe our technique for inserting the TVT device, based upon the original technique described in 1996 [<a href="#rid6">6,36</a>]. The mean operative time for this procedure is 30 minutes [<a href="#rid37">37</a>]. A video of the procedure is included  (<a class="graphic graphic_movie graphicRef67708" href="/z/d/graphic/67708.html" rel="external">movie 1</a>). </p><p class="headingAnchor" id="H2816425"><span class="h2">Operative setting</span><span class="headingEndMark"> — </span>Midurethral sling placement is typically performed in an operating room as an outpatient procedure.</p><p class="headingAnchor" id="H579368"><span class="h2">Anesthesia</span><span class="headingEndMark"> — </span>Midurethral sling placement may be performed under local, regional, or general anesthesia. Many surgeons combine local anesthesia with conscious sedation.</p><p>The TVT procedure was initially described using local anesthesia with conscious sedation [<a href="#rid6">6</a>]. The rationale for this approach is that a patient who is awake and has no abdominal muscle blockade can perform a urinary stress (cough) test, allowing sling tension to be adjusted if leakage of urine is noted [<a href="#rid38">38</a>]. The urinary stress test is described separately. (See  <a class="medical medical_review" href="/z/d/html/6874.html" rel="external">"Female urinary incontinence: Evaluation", section on 'Clinical tests'</a>.)</p><p>The use of regional anesthesia alters the results of the urinary stress test, but does not appear to affect sling success rates. When the urinary stress test is performed under regional anesthesia, less intraabdominal pressure is generated by the cough, but urethral resistance is lower (increasing the tendency to leak urine) [<a href="#rid39">39,40</a>]. These conditions differ from normal function, and thus, it is uncertain whether it is valid to adjust the sling tension based upon these results. In contrast, periurethral infiltration of local anesthetic does not appear to alter urethral function [<a href="#rid41">41</a>]. </p><p>In our practice, we do not routinely perform a urinary stress test, regardless of type of anesthesia, since there is no evidence that the results of the test impact outcome.</p><p>The efficacy of sling placement under regional anesthesia was demonstrated in a randomized trial comparing spinal and local anesthesia in 103 women undergoing a TVT procedure [<a href="#rid39">39</a>]. At 13-month follow-up, the spinal and local anesthesia groups showed no significant differences in subjective SUI cure rates (97 versus 94 percent) and postoperative urinary retention (14 versus 12 percent). Patient comfort level during the procedure was not assessed in this study. </p><p>Use of general anesthesia may be associated with detrimental effects on midurethral sling outcomes. The best available data comparing midurethral sling placement under local or regional anesthesia with general anesthesia are from two large prospective cohort studies [<a href="#rid42">42,43</a>]. In one study (n = 809), at two-year follow-up, a lower subjective SUI cure rate was associated with general anesthesia compared with local anesthesia (68 versus 81 percent) [<a href="#rid43">43</a>]. In another study (n = 500), the rate of postoperative voiding dysfunction was significantly higher in women who received general anesthesia (17 versus 6 percent) [<a href="#rid42">42</a>]. </p><p>Based upon these data, we suggest use of local anesthesia with conscious sedation or regional anesthesia rather than general anesthesia for midurethral sling placement, when it is being performed as an isolated procedure. General anesthesia may be used if it is preferred by the patient or if it is required for a concomitant procedure.</p><p class="headingAnchor" id="H299003"><span class="h2">Instrumentation</span><span class="headingEndMark"> — </span>The TVT system consists of a metal handle to which two metal needles and sling can be attached. The sling is 40 cm long and 1 cm wide covered by a plastic sheath, and the outer diameter of the trocar is 5 to 6 mm. Variations of this system have ≤3 mm trocars with plastic sheaths that cover the trocars as well as the connected sheathed 1 cm wide polypropylene sling.</p><p>Additional surgical equipment includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Bladder (Foley) catheter (size 16 to 18 French)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rigid catheter guide</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cystoscope</p><p></p><p>Use of size 18 French will allow the rigid catheter guide to be more easily introduced but is not necessary. This catheter guide is used to deviate the bladder away from the side of trocar placement. </p><p class="headingAnchor" id="H299019"><span class="h2">Sling placement</span><span class="headingEndMark"> — </span>Placement of a bottom-to-top full-length retropubic midurethral sling is performed as follows:</p><p class="headingAnchor" id="H4700151"><span class="h3">Patient preparation</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient set-up</strong> – Position the patient in dorsal lithotomy with careful attention to avoid nerve compression. (See  <a class="medical medical_review" href="/z/d/html/2882.html" rel="external">"Nerve injury associated with pelvic surgery"</a> and  <a class="medical medical_review" href="/z/d/html/2882.html" rel="external">"Nerve injury associated with pelvic surgery", section on 'Prevention of nerve injury'</a>.)</p><p></p><p class="bulletIndent1">Sterilely prepare and drape the patient. Insert the bladder catheter. The bladder should be completely drained prior to dissection and again prior to placement of the catheter guide.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Marking abdominal incisions </strong>– Mark the two planned abdominal exit points for the tape at the superior margin of the pubic bone, 2 cm lateral to the midline. Some surgeons make small stab incisions at these locations to facilitate trocar passage through the skin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hydrodissection </strong>– Some surgeons hydrodissect the vaginal incision site and/or the path of the trocars. Either local anesthetic (with or without <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>) or sterile <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> may be used. In the original description of the procedure, 40 mL of fluid was injected into the vaginal wall inferior and lateral to the urethra [<a href="#rid6">6</a>]. An additional 60 to 70 mL of fluid was injected at the planned abdominal incision sites and downward along the back of the pubic bone to the retropubic space. Alternatively, fluid may be injected into the retropubic space through the vaginal sulci.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Midurethral vaginal incision</strong> – Make a vertical (longitudinal) vaginal incision, starting 1 cm proximal to the urethral meatus and 1 to 1.5 cm in length to accommodate the width of the sling in the appropriate location. Place Allis clamps on the lateral edges of the incision to provide exposure by retracting the vaginal mucosa laterally. The best ways to prevent a midurethral sling from being too proximal are to start the vaginal incision for the midurethral sling 1 cm from the urethral meatus, as recommended by Ulmsten in the original TVT publication, and to never use an anterior repair incision to place the midurethral sling [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1">Minimal dissection lateral to the midurethra, between the vaginal mucosa and the pubocervical fascia, is performed bilaterally with the Metzenbaum scissors. The scissors are angled towards the retropubic space just behind the pubic symphysis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lateral deviation of the bladder</strong> – Drain the bladder completely, and introduce the rigid catheter guide into the bladder catheter. Deviate the bladder to the side opposite of trocar insertion.</p><p></p><p class="headingAnchor" id="H4700179"><span class="h3">Initial trocar insertion</span><span class="headingEndMark"> — </span>Insertion of the trocar along the correct path is the critical part of the procedure to ensure that the procedure is effective and to avoid complications.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>General insertion procedure </strong>– Insert the first trocar into the tract lateral to the urethra that was dissected out with Metzenbaum scissors. Pass the trocar behind the pubic symphysis (through the retropubic space) and exit through the abdominal incision sites. The trocar or plastic trocar sheath is left in place with the tip just past the level of the abdominal skin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Techniques to prevent complications</strong> – The trocars must be passed along the correct path without deviation to avoid complications. Small deviations of the trocar handle create a magnified deviation of the tip of the trocar, resulting in potential injury to adjacent structures.</p><p></p><p class="bulletIndent1">Deviation of the trocar in a cephalad direction may result in injury to bowel, bladder, or blood vessels [<a href="#rid44">44</a>]. </p><p></p><p class="bulletIndent1">Deviation of the trocar lateral to the posterior surface of the pubic symphysis may cause serious vascular injury. Major vessels (eg, external iliac vessel, obturator vessels, epigastric vessels) may be located as close as 0.9 cm from the correct path of the trocars and the mean distance from the trocar to the major vessels is 3.2 to 4.9 cm (range 0.9 to 6.6 cm)  (<a class="graphic graphic_figure graphicRef70874" href="/z/d/graphic/70874.html" rel="external">figure 4</a>) [<a href="#rid44">44</a>].</p><p></p><p class="bulletIndent1">Techniques for successful placement include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The operator must maintain a firm grasp of the trocar and handle while manipulating the needle through the tissues. Resistance of the tissues may sometimes result in deviation of the needle. Use a hand in the vagina to control and direct the trocar while the opposite hand on the handle is used to apply gentle force to advance the trocar.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Care should be taken to aim the trocar handle in the direction of the outer aspect of the patient's ipsilateral shoulder [<a href="#rid44">44</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The tip of the trocar should be positioned just behind the pubic symphysis. It is often helpful to actually place the tip of the trocar on the underside of the pubic symphysis and to gently slide it behind the bone, staying as close to the bone as possible. To do this, the surgeon must lower the hand that is holding the trocar handle so that the curve of the insertion needle follows the posterior surface of the pubic bone through the retropubic space. The trocar should pass easily in the retropubic space in direct opposition to the posterior side of the symphysis. Later, more force is needed when the trocar passes through the rectus sheath and then out through the skin at the suprapubic level.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The trocar handle must be kept parallel to the floor during retropubic passage to prevent the lateral rotation of the trocar tip.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>After insertion, the anterior vaginal sulci are inspected and palpated to ensure that they have not been perforated by the trocar. If there is a perforation, then the trocar or the plastic sheaths with the mesh can be seen traversing the vaginal sulcus. The first sign of a vaginal perforation is often the onset of vaginal bleeding that does not appear to be coming from the midurethral vaginal incision.</p><p></p><p class="headingAnchor" id="H4700435"><span class="h3">Cystourethroscopy</span><span class="headingEndMark"> — </span>After the trocars are placed, cystourethroscopy is performed to inspect for bladder perforation. A 70 degree cystoscope should be used and the bladder filled adequately to allow complete examination of the urethra and bladder surface [<a href="#rid6">6</a>]. Examination of the bladder requires an experienced clinician; a study of surgical trainees reported that 37 percent of bladder injuries were missed on cystourethroscopy [<a href="#rid45">45</a>]. (See  <a class="medical medical_review" href="/z/d/html/3288.html" rel="external">"Diagnostic cystourethroscopy (cystoscopy) for gynecologic conditions"</a>.)</p><p>Although ureteral injury is extremely uncommon, intravenous administration of 10 percent sodium <a class="drug drug_general" data-topicid="8461" href="/z/d/drug information/8461.html" rel="external">fluorescein</a> (0.25 mL) may be used to check for ureteric flow if ureteral injury is suspected [<a href="#rid46">46</a>]. This has been used with success in our practice due to the unavailability of indigotindisulfonate sodium (<a class="drug drug_general" data-topicid="9088" href="/z/d/drug information/9088.html" rel="external">indigo carmine</a>). (See  <a class="medical medical_review" href="/z/d/html/3276.html" rel="external">"Urinary tract injury in gynecologic surgery: Identification and management"</a>.)</p><p class="headingAnchor" id="H2451122"><span class="h3">Completing the trocar insertion</span><span class="headingEndMark"> — </span>The next step in the procedure depends upon the findings of cystourethroscopy:</p><p class="bulletIndent1"><span class="glyph">●</span>If there is no bladder injury after both trocars are placed, then urethroscopy is performed and the procedure is continued. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If a bladder perforation has occurred, the perforating trocar or sheath should be withdrawn and the bladder emptied completely. The trocar can then be replaced while hugging the posterior surface of the pubic bone. Cystourethroscopy is repeated. This can usually be accomplished even in the presence of a bladder perforation since the defects at the perforation sites result in only a minimal amount of fluid loss. If there is no further bladder injury, then the procedure is continued.</p><p></p><p>When both trocars have been inserted and cystourethroscopy is complete, the remaining portions of both trocars (or plastic trocar sheaths) and the mesh are then passed through the skin. The plastic sheaths are left in place, and the mesh is left slack at the midurethra to allow the tension to be adjusted.</p><p class="headingAnchor" id="H4700493"><span class="h3">Adjusting sling tension</span><span class="headingEndMark"> — </span>To ensure that the sling is tension-free and does not compress the urethra while the patient is at rest, many surgeons insert an instrument (eg, Kelly clamp, Heaney clamp, mayo scissors, needle holder, or number 8 Hegar dilator) between the sling and the urethra while adjusting the sling tension. Others have used a Babcock clamp to pinch a segment of the mesh under the urethra during insertion that then ensures some laxity in the sling when this clamp is released after adjustment [<a href="#rid47">47</a>]. The important concept is that the sling functions by preventing descent of the midurethra during intraabdominal pressure events, and it should not compress or be adjacent to the urethra at rest.</p><p>An intraoperative urinary (cough) stress test may be performed at this time if the patient is under local anesthesia. If leakage occurs, the sling is tightened slightly. In our practice, we do not routinely perform a urinary stress test, regardless of type of anesthesia, since there is no evidence that the results of the test impact outcome. (See <a class="local">'Anesthesia'</a> above.) </p><p>With the spacer in place, remove the plastic sheaths; this prevents excess tightening of the mesh during plastic sheath removal. The surgeon should assess the entire plastic sheath to confirm that it has been completely removed.</p><p>Trim the mesh at the abdominal incisions. Mesh protrusion and irritation at the skin surface can be prevented by depressing the skin slightly to trim the mesh just below the skin surface. The authors keep the spacer in place during mesh trimming to prevent further tightening during mesh elevation for trimming. Based on the authors' experiences, a small gap should remain visible between the sling and the urethra at rest when adjustment is final. The mesh does not require suturing since it is held in by friction and then fibrosis [<a href="#rid6">6</a>].</p><p class="headingAnchor" id="H4700982"><span class="h3">Closure of incisions</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vaginal incision</strong> – We believe everting the edges of the vaginal incision is important to increase the distance between the mesh and the incision line to reduce the risk of vaginal mesh exposure. At our institution, we close the vaginal mucosa with a horizontal mattress suture and use an absorbable suture [<a href="#rid48">48</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Suprapubic skin incisions</strong> – This can be performed in a variety of ways (suture, adhesive strips, surgical glue, no closure), based upon surgeon preference.</p><p></p><p class="headingAnchor" id="H22194879"><span class="h2">Postoperative voiding trial</span><span class="headingEndMark"> — </span>A voiding trial is performed prior to patient discharge. In a retrospective review of nearly 170 women who underwent a retropubic midurethral sling insertion, 80 percent had a successful voiding trial in the same day, and 97 percent had a successful voiding trial within one day [<a href="#rid49">49</a>]. In multivariate analysis, risk factors for delayed voiding included age ≥65 years and use of Valsalva voiding. In a different retrospective case-control study of 464 women, approximately 80 percent of women also had a successful initial voiding trial; medical comorbidities were predictive of an unsuccessful voiding trial in this study [<a href="#rid50">50</a>].</p><p>A voiding trial can be performed in two different ways: retrograde or spontaneous filling of the bladder.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Retrograde bladder filling</strong> – The bladder catheter is left in place at the end of the procedure. Once the patient has completely recovered from anesthesia, the bladder is completely drained through the catheter. The bladder catheter can then be attached to a catheter-tipped syringe with the piston removed or an irrigation syringe. Using only gravity to fill, 300 mL of sterile normal <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> or water at room temperature is instilled into the bladder. The catheter is then removed, and the patient is asked to void in a toilet hat or measured container. The postvoid residual volume is calculated (by subtracting the voided volume from the volume instilled). Although there is no consensus on a residual that implies a low rate of subsequent urinary retention, we consider a successful voiding trial to be a postvoid residual that is &lt;150 mL or less than half the filled amount. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spontaneous bladder filling</strong> – The bladder catheter is removed at the end of the procedure. Once the patient has completely recovered from anesthesia and feels that her bladder is full, she is asked to void. The voided volume is collected and measured and the postvoid residual volume is measured either using a bladder ultrasound or a bladder catheter. A successful voiding trial can be defined as a postvoid residual of &lt;150 mL. </p><p></p><p>It is uncertain which approach to bladder filling is superior. This question has been evaluated in two randomized trials of women who underwent transvaginal surgery [<a href="#rid51">51,52</a>]. In one trial, the proportion of women that had an unsuccessful voiding trial and were discharged home with a bladder catheter was significantly lower in the retrograde group (32 versus 62 percent) [<a href="#rid52">52</a>], while in the other trial, the rate of unsuccessful trials was the same for both groups (65 percent) [<a href="#rid51">51</a>]. The different findings may reflect the different methodology of the two trials; in one, the voiding trial was performed within hours of the end of the procedure [<a href="#rid52">52</a>] and, in the other, two voiding trials were performed on the first postoperative day [<a href="#rid51">51</a>]. In addition, the applicability of these results to midurethral sling placement is somewhat limited, since many participants in both trials (55 to 60 percent) underwent procedures other than sling placement. </p><p>If a patient fails her voiding trial, she can either go home with an indwelling bladder catheter or she can be taught intermittent self-catheterization. Women who fail the voiding trial can be reassured that their surgical success rate is not compromised and some evidence suggests it may be higher [<a href="#rid53">53</a>]. Management of women with postoperative voiding dysfunction is described below. (See <a class="local">'Postoperative catheter management'</a> below.)</p><p class="headingAnchor" id="H25744489"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Retropubic midurethral sling placement is a minimally invasive procedure and complications are uncommon [<a href="#rid54">54</a>]. The most frequent complications of this procedure are bladder perforation, voiding dysfunction, and development of urinary urgency symptoms. </p><p class="headingAnchor" id="H4701067"><span class="h2">Urinary tract complications</span></p><p class="headingAnchor" id="H4700528"><span class="h3">Bladder injury</span><span class="headingEndMark"> — </span>Intraoperative bladder perforation is the most common complication of retropubic midurethral sling placement. In studies of 200 or more procedures, the reported rate ranges between 2 to 6.6 percent [<a href="#rid54">54-59</a>]. In large registries including up to 4281 women, the bladder perforation rate was low (2.7 to 3.9 percent) [<a href="#rid22">22</a>]. Bladder perforation does not appear to be associated with reduced SUI cure rates or with long-term sequelae [<a href="#rid55">55</a>]. </p><p>The likelihood of bladder perforation depends upon the surgeon's experience. A report of 600 procedures performed by an experienced surgeon had a 1 percent rate of bladder perforation [<a href="#rid60">60</a>], while inexperienced operators have reported rates ranging from 15 to 34 percent [<a href="#rid45">45,61</a>].</p><p>Bladder perforation is usually diagnosed with intraoperative cystoscopy. Leaving the trocar in place prior to cystourethroscopy facilitates identification of this type of injury. Bladder management after perforation depends upon the site and extent of perforation. Bladder perforations in the posterior bladder closer to the vaginal incision are theoretically at a higher risk of fistula formation than the more common anterior perforations near the dome of the bladder. Management varies, but surgeons typically continuously drain the bladder with a urethral catheter in place for one to several days [<a href="#rid45">45</a>]. However, in a retrospective study, 25 women with a bladder perforation passed a voiding trial on the day of the procedure and were discharged without a catheter and had no adverse events, suggesting that patients with perforation who do not have gross hematuria and pass a voiding trial at discharge may be safely discharged without a catheter [<a href="#rid62">62</a>]. In our practice, after the more common anterior/lateral perforation, we leave the bladder catheter in place for less than a day and typically remove the catheter without an imaging study. A posterior perforation near the trigone and near the vaginal incision is uncommon but more concerning; we drain the bladder for at least seven days and perform a cystogram to exclude extravasation before discontinuing the bladder drainage. (See <a class="local">'Initial trocar insertion'</a> above.) </p><p>It is important to recognize bladder and urethral perforations at the time of the initial procedure because delayed recognition is associated with significantly more morbidity. Occult bladder injury should be suspected if fluid leaks persistently from the vagina or the abdominal incision sites [<a href="#rid63">63</a>]. Unrecognized injuries appear to occur more frequently in women with prior retropubic surgery. In women in whom bladder perforation is recognized after the mesh has been passed, we remove all of the sling material from the bladder. This may be performed using laparotomy, cystoscopy, or cystoscopy assisted by suprapubic laparoscopic instruments. </p><p>Another mechanism of bladder injury is erosion of the mesh through the bladder wall; this complication is uncommon and the incidence is unknown [<a href="#rid64">64,65</a>]. Some reported cases of mesh erosion may have been bladder perforations that were not recognized at the time of surgery. Others may represent a true erosion of mesh that slowly extrudes through the tissue over time.</p><p>Vesical erosion typically presents several weeks to months postoperatively as urinary urgency, hematuria, or bladder stones [<a href="#rid65">65-67</a>]. This condition is diagnosed with cystoscopy. There are a variety of management options, including: cystoscopic resection using laser or scissors, cystoscopic-guided suprapubic laparoscopic resection, and suprapubic telescopy (cystoscopy through a suprapubic incision) with suprapubic or transurethral instrumentation. Depending upon the severity of the erosion and whether a fistula is present, sometimes a complete transvaginal or transabdominal reconstructive procedure is warranted. </p><p class="headingAnchor" id="H4701082"><span class="h3">Urethral injury</span><span class="headingEndMark"> — </span>Intraoperative urethral perforation or laceration occurs in approximately 0.9 percent of midurethral retropubic sling placements [<a href="#rid68">68</a>]. This type of complication may be diagnosed during cystourethroscopy. When recognized immediately, in our practice, we do not complete the procedure, since we consider this a high risk situation for urethral mesh erosion. We then leave a urethral catheter in place for seven days. The midurethral sling may be performed at a later time after urethral healing. </p><p>Rarely, urethral injury is not recognized immediately or injury occurs postoperatively due to mesh erosion [<a href="#rid68">68-71</a>]. These injuries often present several weeks or months postoperatively with periurethral discomfort, hematuria, voiding difficulty, or irritative voiding symptoms. Urodynamic evaluation may reveal evidence of outflow obstruction. Management includes excision of the eroded portion of the mesh and urethroplasty with the use of local flaps where necessary [<a href="#rid72">72,73</a>].</p><p class="headingAnchor" id="H4701170"><span class="h3">Urinary tract infection</span><span class="headingEndMark"> — </span>Urinary tract infection is a common complication after midurethral sling placement [<a href="#rid74">74</a>]. In one large study of 13,404 midurethral sling surgeries, 23 percent of patients developed a urinary tract infection within the first 12 months, most of which were diagnosed within the first month. Increased age, diabetes, and having urinary retention requiring catheterization were predictors of urinary tract infection [<a href="#rid75">75</a>]. Urinary tract infection should be treated, as appropriate.</p><p class="headingAnchor" id="H4701484"><span class="h3">Voiding dysfunction</span><span class="headingEndMark"> — </span>Urinary retention or incomplete bladder emptying are commonly reported after retropubic midurethral sling placement [<a href="#rid76">76</a>]. The reported rate of voiding dysfunction varies from 19.7 to 47 percent of cases, depending upon the definition and diagnostic criteria used [<a href="#rid52">52,57</a>]. In our practice, we define incomplete bladder emptying as a postvoid residual volume of &gt;150 mL. </p><p>In the Trial of Midurethral Sling (TOMUS) study, no preoperative urodynamic variable was identified that could predict postoperative voiding dysfunction [<a href="#rid77">77</a>]. However, other studies have reported that women with a preoperative maximum urinary flow rate &lt;15 mL/sec compared with those with a rate &gt;30 mL/sec had higher rates of postoperative voiding dysfunction (27 to 67 versus 4 percent) [<a href="#rid78">78,79</a>]. Preoperative counseling for patients who undergo urodynamics and have a maximum flow rate of &lt;15 mL/sec may include a discussion of an increased risk of requiring short-term catheterization. </p><p class="headingAnchor" id="H22194935"><span class="h4">Postoperative catheter management</span><span class="headingEndMark"> — </span>Various management strategies have been used for post-sling voiding dysfunction, including:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intermittent self-catheterization</strong> – The patient self-catheterizes after each void and records the postvoid residual in a voiding diary. Catheterization is discontinued when the postvoid residuals are consistently &lt;150 mL.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indwelling bladder catheter</strong> – The bladder catheter is left in place and a voiding trial performed every three to four days until the postvoid residual is &lt;150 mL.</p><p></p><p>In our practice, we usually start with an indwelling bladder catheter, followed by intermittent self-catheterization. If that approach is not successful, then we perform sling loosening or a sling release. Urethral dilation may be considered in the early postoperative period prior to tissue ingrowth into the sling. However, too much traction on the sling theoretically increases the risk of mesh erosion into the urethra, and, in general, this procedure is discouraged. </p><p>For urinary retention that lasts longer than a few days, clean intermittent self-catheterization is preferable to a long-term indwelling catheter to reduce the risk of urinary tract infection. (See  <a class="medical medical_review" href="/z/d/html/8090.html" rel="external">"Placement and management of urinary bladder catheters in adults", section on 'Choice of catheter'</a>.)</p><p>Antibiotic prophylaxis is not required for short- or long-term bladder catheter use. Antimicrobial therapy should be reserved for patients with a urinary tract infection. (See  <a class="medical medical_review" href="/z/d/html/8090.html" rel="external">"Placement and management of urinary bladder catheters in adults", section on 'Prophylactic antibiotics'</a>.)</p><p class="headingAnchor" id="H2024127996"><span class="h4">Sling adjustment</span></p><p class="headingAnchor" id="H4702658"><span class="h5">Loosening</span><span class="headingEndMark"> — </span>While most cases of postoperative urinary retention resolve with expectant management, persistent voiding dysfunction requires surgical intervention in the form of a sling loosening or release [<a href="#rid80">80-82</a>]. The timing of sling loosening or release is controversial. Most voiding dysfunction resolves spontaneously, so if there is improvement, the patient can be observed for up to six weeks [<a href="#rid77">77</a>]. However, if there is complete retention or small voids with large residuals, a sling loosening at one to two weeks after the initial procedure is reasonable. After two weeks, tissue ingrowth rarely allows sling loosening. Sling loosening can be performed in the office or in the operating room by removing the vaginal incision sutures, isolating the sling, placing an instrument behind the sling and applying gradual downward traction on the sling until it loosens, and then reclosing the incision. If this does not resolve the obstruction, then a sling release will be needed. </p><p class="headingAnchor" id="H1876655375"><span class="h5">Release</span><span class="headingEndMark"> — </span>In a study of billing codes of over 180,000 women who underwent a midurethral sling procedure between 2001 and 2010, the cumulative rate of sling release performed for the indication of urinary retention was 1.3 percent at nine years postoperatively [<a href="#rid83">83</a>]. The rate increased from 0.8 percent at six months postoperatively to 1.1 percent at two years and then generally plateaued. Similarly low rates of sling release due to urinary retention were reported in a large retrospective cohort that included 10,750 retropubic sling procedures [<a href="#rid84">84</a>].</p><p>Sling release relieves urinary retention in most women and SUI recurs in some, but not all, women. Studies of 1000 or more procedures have reported persistent voiding dysfunction following 0.6 to 2.0 percent of midurethral sling procedures [<a href="#rid85">85,86</a>]. There are few data regarding the results of sling release. In a retrospective study of 23 women who underwent sling release following TVT: all patients had complete resolution of urinary retention; 14 (61 percent) had complete cure of SUI; 6 (26 percent) had partial improvement in SUI symptoms; and 3 (13 percent) had failure of SUI treatment [<a href="#rid85">85</a>]. Another study of 50 women who had sling release reported that urinary retention did not completely resolve in 4 patients (12 percent) [<a href="#rid86">86</a>]. </p><p>At our institution, we perform sling release in the operating room with local, regional, or general anesthesia, as appropriate. We use the following procedure for sling release: </p><p class="bulletIndent1"><span class="glyph">●</span>Inject local anesthesia or dilute <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">vasopressin</a> for hydrodissection at the midurethral portion of the vagina.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Incise the vaginal mucosa in the midline overlying the sling.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Identify the sling. The sling can often be identified with palpation or by transilluminating the urethra with a urethroscope to determine its location.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Isolate the entire width of the sling from the urethra; this should be accomplished before any attempt at transection, to ensure that the sling is completely transected. This step is sometimes challenging and requires that an instrument (eg, thin tipped right-angle clamp) is inserted behind the sling. Care is taken during the dissection to isolate only the sling without compromising the urethra. Placement of a bladder catheter before this step is often helpful.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Transect the sling completely. After transection, both ends typically retract slightly.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Perform urethroscopy to ensure that urethral damage has not occurred and then close the vagina in layers, if possible.</p><p></p><p class="headingAnchor" id="H4701601"><span class="h3">Urinary urgency</span><span class="headingEndMark"> — </span>Urinary urge symptoms (eg, urgency, urgency incontinence, frequency) develop in some women following retropubic midurethral sling placement. The reported incidence ranges widely from 5.9 percent to 25 percent [<a href="#rid80">80,87,88</a>]. </p><p>In the immediate postoperative period, transient urge symptoms were believed to be a result of pelvic hematomas. However, one study reported a 17 percent retropubic hematoma formation after surgery but did not find a significant association between de novo LUTS and retropubic hematomas [<a href="#rid89">89</a>]. The etiology of new irritative urinary symptoms is thought to be a combination of mild urinary obstruction and urethral irritation associated with the sling. In one study, 15 of 29 women with post-sling de novo urge symptoms were successfully treated with anticholinergic medications, which are early line therapies for other etiologies of urinary urge symptoms [<a href="#rid88">88</a>]. </p><p>Evaluation and management of urinary urgency symptoms are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6874.html" rel="external">"Female urinary incontinence: Evaluation"</a>.)</p><p class="headingAnchor" id="H4701133"><span class="h3">Other urinary tract complications</span><span class="headingEndMark"> — </span>Ureteral injury is rare. As an example, in a survey study that included 12,280 midurethral sling procedures, only two ureteral injuries were reported [<a href="#rid90">90</a>].</p><p>Urinary tract fistula is a rare, but serious, complication of midurethral sling placement [<a href="#rid68">68,91,92</a>]. Isolated cases of vesicovaginal and urethrovaginal fistulas have been reported. </p><p>Evaluation and management of urinary tract fistulas are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/8071.html" rel="external">"Urogenital tract fistulas in females"</a>.)</p><p class="headingAnchor" id="H4700557"><span class="h2">Vascular injury</span><span class="headingEndMark"> — </span>Occasional vascular injury occurs during retropubic midurethral sling placement, due to the blind passage of the trocars through the highly vascular retropubic space. Injury may involve the paravesical veins, obturator, external iliac, femoral, inferior epigastric or circumflex vessels. Hemorrhage (defined as &gt;500 mL of blood loss) and/or blood transfusion has been reported in approximately 2.5 percent of cases [<a href="#rid57">57,93</a>]. Excessive bleeding can be managed intraoperatively with direct pressure on the paraurethral or retropubic areas [<a href="#rid94">94,95</a>].</p><p>Venous injury typically results in a self-limited slowly expanding retropubic hematoma. Hematoma formation may result in symptoms of bladder compression (suprapubic pain, urinary urgency, urinary frequency) and/or signs of significant blood loss (tachycardia, hypotension, anemia, oliguria). Abdominal and bimanual pelvic examination may reveal a palpable mass in the suprapubic or retropubic spaces (this may be either large or small) and/or ecchymoses in the suprapubic area (bruising may track to the labia). If no signs of hematoma are evident on physical examination, a diagnosis can be made with sonography or computed tomography [<a href="#rid96">96</a>]. One study of 14 women who underwent sonographic evaluation of retropubic hematomas reported that the volume of blood in the hematoma predicted the severity of symptoms: &lt;100 mL (rarely symptomatic); 100 to 200 mL (moderate pain); and &gt;300 mL (severe pain requiring surgical evacuation) [<a href="#rid96">96</a>]. </p><p>Retropubic venous bleeding can often be managed with close observation and conservative management. A study that followed five patients with serial ultrasound noted that it took one to five months for retropubic hematomas to resolve [<a href="#rid96">96</a>].</p><p>Acute hemodynamic decompensation suggests arterial bleeding and requires invasive measures and supportive care (eg, fluid management, transfusion) [<a href="#rid93">93</a>]. Radiographic embolization of arterial vessels associated with the retropubic hemorrhage is the preferred option in a stable patient [<a href="#rid95">95</a>]. Large hematomas may be the result of large vessel damage and may also lead to life-threatening blood loss [<a href="#rid64">64</a>]. In an unstable patient, or if radiographic embolization is unavailable, emergency laparotomy is indicated. One study reported the incidence of massive hematomas (defined as greater than 8 cm in size and/or a drop in hemoglobin &gt;4 g/dL) was 0.33 percent (7 of 2091 retropubic midurethral slings). The majority of these hematomas presented acutely with abdominal pain and hypotension and required blood transfusions and evacuation of their clot via laparotomy [<a href="#rid97">97</a>].</p><p class="headingAnchor" id="H3907444"><span class="h2">Bowel injury</span><span class="headingEndMark"> — </span>Bowel perforation is a rare, but serious, complication of retropubic midurethral sling procedures [<a href="#rid98">98</a>]. There are few data regarding the incidence of this type of injury. A survey of surgeons who had performed a total of over 12,000 TVT procedures reported three bowel perforations [<a href="#rid90">90</a>]. Delayed erosion of the mesh into bowel has also been described [<a href="#rid99">99</a>]. There are also rare cases of sigmoid bowel perforation with TVT trocar that led to a colocutaneous fistula [<a href="#rid100">100</a>] as well as a cecal perforation with TVT [<a href="#rid101">101</a>]. From the time of the introduction of the TVT device in the late 1990s through 2004, the US Food and Drug Administration Manufacturer and User Facility Device Experience database had recorded a total of seven deaths associated with the device, six of which were related to bowel injury [<a href="#rid102">102</a>]. </p><p>Women with prior abdominal or pelvic surgery or women who have an abdominal or inguinal hernia appear to have an increased risk of bowel injury during sling placement [<a href="#rid19">19,103-106</a>]. A transobturator midurethral sling may be preferable for these patients. (See <a class="local">'Contraindications'</a> above and  <a class="medical medical_review" href="/z/d/html/15908.html" rel="external">"Surgical management of stress urinary incontinence in females: Choosing a type of midurethral sling", section on 'Choosing among midurethral slings'</a>.)</p><p>A measure that has been proposed to prevent bowel injury is to place the patient in steep Trendelenburg position to allow the bowel to shift out of the retropubic area [<a href="#rid107">107</a>]. In our practice, we may use slight, but not steep, Trendelenburg.</p><p>Bowel perforation is a surgical emergency. Women with severe or persistent abdominal pain following retropubic midurethral sling placement should be evaluated for bowel injury. Pain may be accompanied by fever and/or feculent or purulent drainage from the abdominal incision sites. Women with suspected bowel injury should undergo imaging with a plain radiograph or computed tomography, and surgical exploration should be expedited, if necessary. (See  <a class="medical medical_review" href="/z/d/html/15075.html" rel="external">"Overview of gastrointestinal tract perforation"</a> and  <a class="medical medical_review" href="/z/d/html/290.html" rel="external">"Evaluation of the adult with nontraumatic abdominal or flank pain in the emergency department"</a>.)</p><p class="headingAnchor" id="H3907598"><span class="h2">Synthetic mesh complications</span><span class="headingEndMark"> — </span>Mesh exposure, previously known as erosion, is a common complication when synthetic mesh is used [<a href="#rid108">108-110</a>]. In a study of billing codes of over 180,000 United States women who underwent a midurethral sling procedure between 2001 and 2010, the cumulative rate of sling release performed for the indication of mesh exposure was 2.5 percent at nine years postoperatively [<a href="#rid83">83</a>]. The rate increased from 0.9 percent at six months postoperatively to 2.2 percent at five years and then generally plateaued. Similar results were reported in a subsequent retrospective, population-based study of British women from the National Health Service hospitals [<a href="#rid111">111</a>]. In that group of over 95,000 women undergoing first midurethral sling insertion between 2006 and 2015, the rates of sling removal were 1.4, 2.7, and 3.3 percent at one, five, and nine years, respectively. The risk of removal at nine years was lower for transobturator slings compared with retropubic slings (2.7 versus 3.6 percent, subdistribution hazard ratio 0.72, 95% CI 0.62-0.84). The overall rates of any sling-related surgery, including mesh removal, were 2.6, 5.5, and 6.9 percent at one, five, and nine years, respectively.</p><p>Common clinical presentations of vaginal mesh exposure include visible or palpable tape in the vagina, vaginal discharge, vaginal bleeding, postcoital spotting, dyspareunia, male sexual partner discomfort (hispareunia), or urinary tract infection. The diagnosis of mesh exposure is made with visual inspection of the vagina. </p><p>Management for vaginal erosions varies with the extent of the erosion and the severity of symptoms. Initial management is with conservative measures, including vaginal estrogen therapy and avoidance of vaginal insertions (tampons, intercourse) [<a href="#rid108">108</a>]. If symptoms persist and/or the patient or her partner can feel the sling and find this bothersome, surgical treatments may be offered. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Reapproximating the vaginal epithelium (this is only possible if there is sufficient tissue) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Excision of the palpable portion of mesh [<a href="#rid108">108</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Partial/complete removal of the mesh [<a href="#rid72">72,112</a>]</p><p></p><p>Patients should be counseled that removal of all or part of the mesh may result in recurrent SUI. (See <a class="local">'Loosening'</a> above.)</p><p>Erosion of mesh into the bladder, urethra, or bowel is discussed separately. (See <a class="local">'Bladder injury'</a> above and <a class="local">'Urethral injury'</a> above and <a class="local">'Bowel injury'</a> above.)</p><p class="headingAnchor" id="H3907605"><span class="h2">Pelvic pain</span><span class="headingEndMark"> — </span>Some women develop chronic pelvic pain following retropubic midurethral sling placement (7.5 percent in one series of 241 women) [<a href="#rid57">57</a>]. Depending upon the severity and duration, pelvic pain may be treated with expectant management, medical therapy, or pelvic physical therapy. Resolution of symptoms with removal of the mesh via laparoscopy or vaginal and thigh incisions was reported in a prospective study of 32 women who developed pelvic and perineal pain following placement of a midurethral sling [<a href="#rid113">113</a>]. At 10-month follow-up, visual analog pain scores improved by at least 50 percent in 68 percent of women; 22 percent had recurrent SUI.</p><p>The evaluation and management of pelvic pain are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5467.html" rel="external">"Chronic pelvic pain in adult females: Evaluation"</a>.)</p><p>Postoperative dyspareunia following retropubic midurethral sling placement has not been routinely reported. However, this complication has been reported following transobturator sling procedures. (See  <a class="medical medical_review" href="/z/d/html/14218.html" rel="external">"Surgical management of stress urinary incontinence in females: Transobturator midurethral slings", section on 'Sexual function'</a>.)</p><p class="headingAnchor" id="H4701050"><span class="h2">Other complications</span><span class="headingEndMark"> — </span>There have been case reports of necrotizing fasciitis [<a href="#rid114">114</a>], ilioinguinal nerve entrapment [<a href="#rid115">115,116</a>], and obturator neuropathy [<a href="#rid117">117</a>] following retropubic midurethral sling placement.</p><p class="headingAnchor" id="H298266"><span class="h1">FOLLOW-UP</span></p><p class="headingAnchor" id="H2816407"><span class="h2">Postoperative care and instructions</span><span class="headingEndMark"> — </span>Women may experience vaginal, periurethral, or lower abdominal discomfort and pain at incision sites for up to two weeks following the procedure. These symptoms are typically well controlled with oral narcotics or nonsteroidal anti-inflammatory drugs. Many women also have vaginal spotting for up to two weeks.</p><p>We counsel patients to call their surgeon if they experience symptoms that may be associated with a serious complication, including: </p><p class="bulletIndent1"><span class="glyph">●</span>Fever</p><p class="bulletIndent1"><span class="glyph">●</span>Heavy vaginal bleeding</p><p class="bulletIndent1"><span class="glyph">●</span>Light-headedness</p><p class="bulletIndent1"><span class="glyph">●</span>Severe or persistent abdominal pain</p><p class="bulletIndent1"><span class="glyph">●</span>Vomiting or persistent nausea</p><p class="bulletIndent1"><span class="glyph">●</span>Discharge of clear fluid or blood from the incision sites that is copious or persistent or any amount of purulent or feculent discharge</p><p></p><p>Patients who present with these symptoms should be promptly evaluated. </p><p>Urinary retention may occur even after a successful postoperative voiding trial. Patients who feel a persistent sense of urinary retention or incomplete bladder emptying should have a postvoid residual volume measured and may require catheterization. (See <a class="local">'Postoperative catheter management'</a> above.) </p><p>The sling is initially held in place solely by frictional tissue forces, and patients must allow adequate time for tissue in-growth to occur before significant intraabdominal pressure is applied to the mesh. Patients are advised to avoid heavy lifting, actions that increase intraabdominal pressure, or exercise for at least two weeks. Ambulation, however, is encouraged. Sexual activity should be avoided until the vaginal epithelium is healed, which takes approximately six weeks.</p><p>The patient may return to work when she feels sufficiently comfortable. </p><p>We see patients for a routine follow-up visit at four to six weeks. We perform abdominal and vaginal examinations to ensure that the incisions have adequately healed and to check for vaginal mesh erosion. The vaginal sulci are visualized and palpated to confirm that there are no occult extrusions of mesh. We check a postvoid residual volume to assess whether the patient has been adequately emptying her bladder. This can be measured with a bladder ultrasound or catheterization. </p><p>Patient information regarding care after pelvic surgery can be found separately. (See  <a class="medical medical_patient" href="/z/d/html/8393.html" rel="external">"Patient education: Care after gynecologic surgery (Beyond the Basics)"</a>.) </p><p class="headingAnchor" id="H4550776"><span class="h2">Persistent or recurrent SUI</span><span class="headingEndMark"> — </span>For patients who present at the postoperative visit after a retropubic midurethral sling procedure and report persistent SUI, the position of the sling should be evaluated. The midurethra is largely considered the continence zone of the urethra and careful positioning of the sling beneath this portion of the urethra has been shown to achieve the highest rates of continence. Clinicians may assess positioning of the sling with palpation along the urethra. They may also check for the presence or absence of urethral hypermobility. </p><p>Three-dimensional transperineal, translabial, and endovaginal ultrasound can be used to evaluate sling position and correlate position with surgical outcomes [<a href="#rid118">118</a>]. Ultrasound can also differentiate between transobturator and retropubic slings, provide information on mesh type, and locate mesh and mesh position which can often be difficult to find on physical examination [<a href="#rid119">119</a>]. As an example, a case control study evaluated 100 patients following transobturator sling surgery [<a href="#rid120">120</a>]. Based upon three-dimensional transperineal ultrasound, a transobturator sling that moved concordantly with the urethra during dynamic testing, was located in the midurethra, and deformed appropriately with stress maneuvers was associated with the best success rates. Unsuccessful slings were often positioned too proximally. </p><p>In our experience, the most common cause of midurethral sling failure is incorrect placement (typically at the bladder neck instead of the mid urethra). When a midurethral sling is too proximal, continence can be achieved by placing a repeat midurethral sling properly under the midurethra without removing the nonfunctioning sling. The majority of patients do very well after repeat retropubic midurethral sling [<a href="#rid121">121</a>].</p><p>In a retrospective cohort of 17,030 patients who underwent a midurethral sling between 2005 and 2016, the cumulative reoperation rate for recurrent SUI was 1.6, 3.9, and 5.2 percent at one, five, and nine years, respectively [<a href="#rid84">84</a>]. The most common operation was the synthetic midurethral sling. Patients who initially had a single incision sling had a much greater risk of needing a reoperation when compared with the retropubic midurethral sling (adjusted hazard ratio 1.5, 95% CI 1.03-2.11). </p><p>The evaluation and management of persistent or recurrent SUI after continence surgery is discussed in detail separately [<a href="#rid122">122</a>]. (See  <a class="medical medical_review" href="/z/d/html/8078.html" rel="external">"Stress urinary incontinence in females: Persistent/recurrent symptoms after surgical treatment"</a>.)</p><p class="headingAnchor" id="H298966"><span class="h2">Subsequent pregnancy</span><span class="headingEndMark"> — </span>Most physicians recommend delaying midurethral sling placement until childbearing has been completed. The rationale includes that pelvic support may be disrupted during pregnancy and birth, particularly following a vaginal birth, and that long-term outcomes data are limited. However, available data suggest that patients with subsequent pregnancy and childbirth are not at increased risk for recurrent SUI symptoms or repeat surgery [<a href="#rid123">123-126</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk of recurrent SUI or repeat surgery</strong> – Childbirth after MUS does not appear to be associated with an increased risk of subsequent SUI or need for repeat surgery [<a href="#rid125">125,126</a>]. A meta-analysis comparing 381 patients with childbirth after MUS placement with 860 patients with MUS only reported similar SUI recurrence and reoperation rates for both groups at a mean duration of follow-up of 9.8 years (range 2 to 18 years) [<a href="#rid125">125</a>]. Absolute SUI recurrence rates ranged from 17 to 24 percent versus 15 to 22 percent (RR 1.02, 95% CI 0.78-1.33), respectively, while reoperation rates were 3 to 12 percent versus 3 to 7 percent (RR 1.37, 95% CI 0.87-2.17). The seven included studies were observational and SUI recurrence was defined subjectively.     </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mode of delivery</strong> – For patients who become pregnant following anti-incontinence surgery, the route of delivery should be determined by patient preference and obstetric indications. Based on the limited data available, the risks of recurrent SUI and reoperation are similar for vaginal and cesarean birth [<a href="#rid125">125,127-130</a>]. We counsel patients that vaginal birth does not appear to increase risk, nor does cesarean birth reduce risk, and discuss the caveats that the available evidence is based on small sample sizes and low numbers of events, in addition to a lack of multi-decade follow-up.</p><p></p><p class="bulletIndent1">Representative studies include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a 2023 meta-analysis comparing 381 patients with childbirth after MUS placement with 860 patients with MUS only, risk of SUI recurrence and reoperation were similar for vaginal and cesarean birth [<a href="#rid125">125</a>]. However, definitive conclusions regarding equivalence were limited by the low number of events and small sample sizes. For SUI recurrence, absolute rates were 4 in 25 (16 percent) versus 2 in 27 (7.4 percent, RR 1.81, 95% CI 0.48-6.80), respectively, and reoperation rates were 13 in 113 (11.5 percent) versus 12 in 139 (8.6 percent, RR 1.42, 95% CI 0.70-2.92). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A 2018 population-based cohort study including 537 Swedish women who became pregnant following midurethral sling surgery reported no differences in SUI rates between pregnant and control women or between the vaginal and cesarean delivery groups [<a href="#rid123">123</a>].  </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A 2018 population-based cohort study of 228 individuals with mid-urethral slings who were followed for 10 years reported that one childbirth did not impact subjective success rates but more than one birth did (subjective success rates of 88 versus 50 percent, respectively) [<a href="#rid124">124</a>]. (See  <a class="medical medical_review" href="/z/d/html/8070.html" rel="external">"Female stress urinary incontinence: Choosing a primary surgical procedure", section on 'Women finished with childbearing'</a>.)</p><p></p><p class="headingAnchor" id="H2819228"><span class="h1">OUTCOME</span><span class="headingEndMark"> — </span>Minimally invasive midurethral slings are widely considered to be the standard of care for women undergoing surgical treatment for SUI [<a href="#rid37">37</a>]. In a meta-analysis of 55 trials including women receiving retropubic slings, short-term subjective cure rates (within 12 months postoperatively) of 71 to 97 percent were reported [<a href="#rid22">22</a>]. In the Trial of Midurethral Slings (TOMUS; n = 597; the largest randomized trial comparing retropubic and transobturator slings to-date), for retropubic slings, the 12-month subjective success rate was 62 percent and the objective cure rate was 78 percent [<a href="#rid37">37</a>]. Patient satisfaction has been reported as over 80 percent at one year postoperatively [<a href="#rid131">131</a>]. </p><p>Long-term data include a prospective cohort study that followed women for up to 17 years after TVT procedures that reported objective cure rates of 90 percent and subjective cure rates of 87 percent [<a href="#rid132">132</a>]. (See  <a class="medical medical_review" href="/z/d/html/8070.html" rel="external">"Female stress urinary incontinence: Choosing a primary surgical procedure", section on 'Comparison of efficacy'</a>.)</p><p>Risk factors for failure of either a retropubic or transobturator sling within one year of placement based upon data from the TOMUS trial included: previous anti-incontinence surgery (twofold increased risk); urgency symptoms (as measured by a questionnaire score; twofold); and maximum Q-tip excursion &lt;30° on preoperative urethral hypermobility testing (1.9-fold) [<a href="#rid133">133</a>]. Objective, but not subjective, failure was associated with age (1.5-fold per 10 years). Having concomitant surgery was associated with a lower risk of subjective, but not objective, failure (0.44-fold).</p><p class="headingAnchor" id="H2183236562"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/122263.html" rel="external">"Society guideline links: Incontinence surgery in women"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/109273.html" rel="external">"Society guideline links: Urinary incontinence in adults"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/122885.html" rel="external">"Society guideline links: Gynecologic surgery"</a>.)</p><p class="headingAnchor" id="H5990108"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, and answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon. (See  <a class="medical medical_basics" href="/z/d/html/15357.html" rel="external">"Patient education: Urinary incontinence in females (The Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/2726.html" rel="external">"Patient education: Urinary incontinence treatments for women (Beyond the Basics)"</a>.)</p><p class="headingAnchor" id="H25744531"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Stress urinary incontinence (SUI) is the involuntary leakage of urine with increased intraabdominal pressure. Midurethral sling placement is the procedure of choice for treatment of SUI in many women. Midurethral slings may be placed either through the retropubic or transobturator spaces. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Relative contraindications for retropubic midurethral sling placement include future plans for pregnancy and an increased risk of injury to retropubic structures (ie, due to prior surgery or a current hernia that may result in the presence of viscera or major vessels in the retropubic space). (See <a class="local">'Contraindications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Women who are planning primary midurethral retropubic sling placement should undergo preoperative evaluation to confirm the diagnosis of SUI, exclude other etiologies of urinary incontinence, confirm normal bladder emptying, and assess surgical risk. (See <a class="local">'Evaluation'</a> above and  <a class="medical medical_review" href="/z/d/html/8088.html" rel="external">"Surgical management of stress urinary incontinence in females: Preoperative evaluation for a primary procedure"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We recommend antibiotic prophylaxis for surgical site infection for surgical procedures for treatment of pelvic organ prolapse or SUI that utilize surgical mesh (<a class="grade" href="https:///uptodate/show/grade_1" rel="external">Grade 1A</a>). (See <a class="local">'Antibiotic prophylaxis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For women undergoing retropubic midurethral sling placement, we suggest a bottom-to-top rather than top-to-bottom approach for trocar insertion (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). (See <a class="local">'Comparison of insertion routes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We suggest use of local anesthesia with conscious sedation or regional anesthesia rather than general anesthesia for midurethral sling placement (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). General anesthesia may be used if it is preferred by the patient or if it is required for a concomitant procedure. (See <a class="local">'Anesthesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>During sling placement, the trocars must be passed along the correct path without deviation to avoid complications. Small deviations of the trocar handle create a magnified deviation of the tip of the trocar, resulting in potential injury to adjacent structures. (See <a class="local">'Initial trocar insertion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Common complications of midurethral retropubic sling placement include bladder perforation, voiding dysfunction, and development of urinary urgency symptoms. Surgeons should be aware of the potential for serious complications, including bowel injury, vascular injury, and urinary tract fistula. (See <a class="local">'Complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Voiding dysfunction following sling placement may be treated initially with bladder catheterization. Persistent symptoms may require sling loosening or sling release (which may result in recurrent SUI). (See <a class="local">'Postoperative catheter management'</a> above and <a class="local">'Sling adjustment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Long-term data show a SUI cure rate of approximately 80 percent following retropubic midurethral sling placement. (See <a class="local">'Outcome'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61:37.</a></li><li><a class="nounderline abstract_t">Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010; 29:4.</a></li><li><a class="nounderline abstract_t">Luber KM. The definition, prevalence, and risk factors for stress urinary incontinence. Rev Urol 2004; 6 Suppl 3:S3.</a></li><li><a class="nounderline abstract_t">Suskind AM, Kaufman SR, Dunn RL, et al. Population-based trends in ambulatory surgery for urinary incontinence. Int Urogynecol J 2013; 24:207.</a></li><li><a class="nounderline abstract_t">Wu JM. Stress Incontinence in Women. N Engl J Med 2021; 384:2428.</a></li><li><a class="nounderline abstract_t">Ulmsten U, Henriksson L, Johnson P, Varhos G. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 1996; 7:81.</a></li><li><a class="nounderline abstract_t">Joint Report on Terminology for Surgical Procedures to Treat Stress Urinary Incontinence in Women. Female Pelvic Med Reconstr Surg 2020; 26:162.</a></li><li><a class="nounderline abstract_t">Sarlos D, Kuronen M, Schaer GN. How does tension-free vaginal tape correct stress incontinence? investigation by perineal ultrasound. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:395.</a></li><li><a class="nounderline abstract_t">Dietz HP, Wilson PD. The 'iris effect': how two-dimensional and three-dimensional ultrasound can help us understand anti-incontinence procedures. Ultrasound Obstet Gynecol 2004; 23:267.</a></li><li><a class="nounderline abstract_t">Shek KL, Dietz HP. Ultrasound imaging of slings and meshes in urogynecology. Ultrasound Obstet Gynecol 2021; 57:526.</a></li><li><a class="nounderline abstract_t">Majercik S, Tsikitis V, Iannitti DA. Strength of tissue attachment to mesh after ventral hernia repair with synthetic composite mesh in a porcine model. Surg Endosc 2006; 20:1671.</a></li><li><a class="nounderline abstract_t">Lo TS, Ng KL, Lin YH, et al. Impact of intrinsic sphincter deficiency on mid-urethral sling outcomes. Int Urogynecol J 2022; 33:887.</a></li><li><a class="nounderline abstract_t">Nager CW, Sirls L, Litman HJ, et al. Baseline urodynamic predictors of treatment failure 1 year after mid urethral sling surgery. J Urol 2011; 186:597.</a></li><li><a class="nounderline abstract_t">Ford AA, Ogah JA. Retropubic or transobturator mid-urethral slings for intrinsic sphincter deficiency-related stress urinary incontinence in women: a systematic review and meta-analysis. Int Urogynecol J 2016; 27:19.</a></li><li><a class="nounderline abstract_t">Liapis A, Bakas P, Creatsas G. Tension-free vaginal tape in the management of recurrent urodynamic stress incontinence after previous failed midurethral tape. Eur Urol 2009; 55:1450.</a></li><li><a class="nounderline abstract_t">Liapis A, Bakas P, Creatsas G. Long-term efficacy of tension-free vaginal tape in the management of stress urinary incontinence in women: efficacy at 5- and 7-year follow-up. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:1509.</a></li><li><a class="nounderline abstract_t">Rezapour M, Falconer C, Ulmsten U. Tension-Free vaginal tape (TVT) in stress incontinent women with intrinsic sphincter deficiency (ISD)--a long-term follow-up. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12 Suppl 2:S12.</a></li><li><a class="nounderline abstract_t">Azam U, Frazer MI, Kozman EL, et al. The tension-free vaginal tape procedure in women with previous failed stress incontinence surgery. J Urol 2001; 166:554.</a></li><li><a class="nounderline abstract_t">Gurshumov EL, Klapper AS, Sierecki AR. Small bowel perforation in a hernia sac after TVT placement at the time of colpocleisis. Int Urogynecol J 2010; 21:371.</a></li><li><a class="nounderline abstract_t">Hoda MR, Wagner S, Greco F, et al. Pelvic organ prolapse management in female kidney transplant recipients. J Urol 2010; 184:1064.</a></li><li><a class="nounderline abstract_t">McNanley AR, Buchsbaum GM. TVT or TOT? When to avoid retropubic trocar passage. Int Urogynecol J 2010; 21:383.</a></li><li><a class="nounderline abstract_t">Ford AA, Rogerson L, Cody JD, Ogah J. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev 2015; :CD006375.</a></li><li><a class="nounderline abstract_t">Mallett VT, Brubaker L, Stoddard AM, et al. The expectations of patients who undergo surgery for stress incontinence. Am J Obstet Gynecol 2008; 198:308.e1.</a></li><li><a class="nounderline abstract_t">Sinha D, Blackwell A, Moran PA. Outcome measures after TVT for mixed urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:927.</a></li><li><a class="nounderline abstract_t">Choe JH, Choo MS, Lee KS. The impact of tension-free vaginal tape on overactive bladder symptoms in women with stress urinary incontinence: significance of detrusor overactivity. J Urol 2008; 179:214.</a></li><li><a class="nounderline abstract_t">Heliker BD, Kenton K, Komar A, et al. Treat or Wait? Natural Perioperative Course of Overactive Bladder Symptoms at the Time of Midurethral Sling Placement. Female Pelvic Med Reconstr Surg 2021; 27:e348.</a></li><li><a class="nounderline abstract_t">Sung VW, Borello-France D, Newman DK, et al. Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery vs Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial. JAMA 2019; 322:1066.</a></li><li><a class="nounderline abstract_t">Madjar S, Frischer Z, Nieder AM, Waltzer WC. Bladder wall abscess following midurethral sling procedure. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:180.</a></li><li><a class="nounderline abstract_t">Lee SY, Kim JY, Park SJ, et al. Bilateral recurrent thigh abscesses for five years after a transobturator tape implantation for stress urinary incontinence. Korean J Urol 2010; 51:657.</a></li><li><a class="nounderline abstract_t">DeSouza R, Shapiro A, Westney OL. Adductor brevis myositis following transobturator tape procedure: a case report and review of the literature. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:817.</a></li><li><a class="nounderline abstract_t">Connolly TP. Necrotizing surgical site infection after tension-free vaginal tape. Obstet Gynecol 2004; 104:1275.</a></li><li><a class="nounderline abstract_t">Sivanesan K, Abdel-Fattah M, Tierney J. Perineal cellulitis and persistent vaginal erosion after transobturator tape (Obtape)--case report and review of the literature. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:219.</a></li><li><a class="nounderline abstract_t">Karsenty G, Boman J, Elzayat E, et al. Severe soft tissue infection of the thigh after vaginal erosion of transobturator tape for stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:207.</a></li><li><a class="nounderline abstract_t">ACOG Practice Bulletin No. 195: Prevention of Infection After Gynecologic Procedures. Obstet Gynecol 2018; 131:e172. Reaffirmed 2022.</a></li><li class="breakAll">American Urologic Association. Urologic surgery antimicrobial prophylaxis. http://www.auanet.org/content/media/antimicroprop08.pdf (Accessed on August 16, 2011).</li><li><a class="nounderline abstract_t">Ulmsten U, Falconer C, Johnson P, et al. A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 1998; 9:210.</a></li><li><a class="nounderline abstract_t">Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med 2010; 362:2066.</a></li><li><a class="nounderline abstract_t">Low SJ, Smith KM, Holt EM. Tension free vaginal tape: is the intra-operative cough test necessary? Int Urogynecol J Pelvic Floor Dysfunct 2004; 15:328.</a></li><li><a class="nounderline abstract_t">Adamiak A, Milart P, Skorupski P, et al. The efficacy and safety of the tension-free vaginal tape procedure do not depend on the method of analgesia. Eur Urol 2002; 42:29.</a></li><li><a class="nounderline abstract_t">Duckett RA, Grapsas P, Eaton M, Basu M. The effect of spinal anaesthesia on urethral function. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:257.</a></li><li><a class="nounderline abstract_t">Duckett JR, Papanikolaou NS, Eaton M. The effect of local anaesthetic infiltration on urethral function during the tension-free vaginal tape (TVT) procedure. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:839.</a></li><li><a class="nounderline abstract_t">Duckett JR, Patil A, Papanikolaou NS. Predicting early voiding dysfunction after tension-free vaginal tape. J Obstet Gynaecol 2008; 28:89.</a></li><li><a class="nounderline abstract_t">Koops SE, Bisseling TM, van Brummen HJ, et al. What determines a successful tension-free vaginal tape? A prospective multicenter cohort study: results from The Netherlands TVT database. Am J Obstet Gynecol 2006; 194:65.</a></li><li><a class="nounderline abstract_t">Muir TW, Tulikangas PK, Fidela Paraiso M, Walters MD. The relationship of tension-free vaginal tape insertion and the vascular anatomy. Obstet Gynecol 2003; 101:933.</a></li><li><a class="nounderline abstract_t">McLennan MT, Melick CF. Bladder perforation during tension-free vaginal tape procedures: analysis of learning curve and risk factors. Obstet Gynecol 2005; 106:1000.</a></li><li><a class="nounderline abstract_t">Doyle PJ, Lipetskaia L, Duecy E, et al. Sodium fluorescein use during intraoperative cystoscopy. Obstet Gynecol 2015; 125:548.</a></li><li><a class="nounderline abstract_t">Brennand EA, Wu G, Houlihan S, et al. Two Intraoperative Techniques for Midurethral Sling Tensioning: A Randomized Controlled Trial. Obstet Gynecol 2020; 136:471.</a></li><li><a class="nounderline abstract_t">Giri SK, Sil D, Narasimhulu G, et al. Management of vaginal extrusion after tension-free vaginal tape procedure for urodynamic stress incontinence. Urology 2007; 69:1077.</a></li><li><a class="nounderline abstract_t">Barr SA, Thomas A, Potter S, et al. Incidence of successful voiding and predictors of early voiding dysfunction after retropubic sling. Int Urogynecol J 2016; 27:1209.</a></li><li><a class="nounderline abstract_t">Ripperda CM, Kowalski JT, Chaudhry ZQ, et al. Predictors of early postoperative voiding dysfunction and other complications following a midurethral sling. Am J Obstet Gynecol 2016; 215:656.e1.</a></li><li><a class="nounderline abstract_t">Pulvino JQ, Duecy EE, Buchsbaum GM, Flynn MK. Comparison of 2 techniques to predict voiding efficiency after inpatient urogynecologic surgery. J Urol 2010; 184:1408.</a></li><li><a class="nounderline abstract_t">Foster RT Sr, Borawski KM, South MM, et al. A randomized, controlled trial evaluating 2 techniques of postoperative bladder testing after transvaginal surgery. Am J Obstet Gynecol 2007; 197:627.e1.</a></li><li><a class="nounderline abstract_t">Ferrante KL, Kim HY, Brubaker L, et al. Repeat post-op voiding trials: an inconvenient correlate with success. Neurourol Urodyn 2014; 33:1225.</a></li><li><a class="nounderline abstract_t">Søgaard NB, Glavind K. Complications and re-operations after tension-free vaginal tape operation in women with stress urinary incontinence. Int Urogynecol J 2021; 32:159.</a></li><li><a class="nounderline abstract_t">Gold RS, Groutz A, Pauzner D, et al. Bladder perforation during tension-free vaginal tape surgery: does it matter? J Reprod Med 2007; 52:616.</a></li><li><a class="nounderline abstract_t">Kristensen I, Eldoma M, Williamson T, et al. Complications of the tension-free vaginal tape procedure for stress urinary incontinence. Int Urogynecol J 2010; 21:1353.</a></li><li><a class="nounderline abstract_t">Abouassaly R, Steinberg JR, Lemieux M, et al. Complications of tension-free vaginal tape surgery: a multi-institutional review. BJU Int 2004; 94:110.</a></li><li><a class="nounderline abstract_t">Dyrkorn OA, Kulseng-Hanssen S, Sandvik L. TVT compared with TVT-O and TOT: results from the Norwegian National Incontinence Registry. Int Urogynecol J 2010; 21:1321.</a></li><li><a class="nounderline abstract_t">Brubaker L, Norton PA, Albo ME, et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol 2011; 205:498.e1.</a></li><li><a class="nounderline abstract_t">Wang AC. The techniques of trocar insertion and intraoperative urethrocystoscopy in tension-free vaginal taping: an experience of 600 cases. Acta Obstet Gynecol Scand 2004; 83:293.</a></li><li><a class="nounderline abstract_t">Bodelsson G, Henriksson L, Osser S, Stjernquist M. Short term complications of the tension free vaginal tape operation for stress urinary incontinence in women. BJOG 2002; 109:566.</a></li><li><a class="nounderline abstract_t">Crosby EC, Vilasagar S, Duecy EE, Flynn MK. Expectant management of cystotomy at the time of midurethral sling placement: a retrospective case series. Int Urogynecol J 2013; 24:1543.</a></li><li><a class="nounderline abstract_t">Abbas Shobeiri S, Garely AD, Chesson RR, Nolan TE. Recognition of occult bladder injury during the tension-free vaginal tape procedure. Obstet Gynecol 2002; 99:1067.</a></li><li><a class="nounderline abstract_t">Deng DY, Rutman M, Raz S, Rodriguez LV. Presentation and management of major complications of midurethral slings: Are complications under-reported? Neurourol Urodyn 2007; 26:46.</a></li><li><a class="nounderline abstract_t">Mustafa M, Wadie BS. Bladder erosion of tension-free vaginal tape presented as vesical stone; management and review of literature. Int Urol Nephrol 2007; 39:453.</a></li><li><a class="nounderline abstract_t">Oh TH, Ryu DS. Transurethral resection of intravesical mesh after midurethral sling procedures. J Endourol 2009; 23:1333.</a></li><li><a class="nounderline abstract_t">Huwyler M, Springer J, Kessler TM, Burkhard FC. A safe and simple solution for intravesical tension-free vaginal tape erosion: removal by standard transurethral resection. BJU Int 2008; 102:582.</a></li><li><a class="nounderline abstract_t">Morton HC, Hilton P. Urethral injury associated with minimally invasive mid-urethral sling procedures for the treatment of stress urinary incontinence: a case series and systematic literature search. BJOG 2009; 116:1120.</a></li><li><a class="nounderline abstract_t">Karram MM, Segal JL, Vassallo BJ, Kleeman SD. Complications and untoward effects of the tension-free vaginal tape procedure. Obstet Gynecol 2003; 101:929.</a></li><li><a class="nounderline abstract_t">Lieb J, Das AK. Urethral erosion of tension-free vaginal tape. Scand J Urol Nephrol 2003; 37:184.</a></li><li><a class="nounderline abstract_t">Powers K, Lazarou G, Greston WM. Delayed urethral erosion after tension-free vaginal tape. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:422.</a></li><li><a class="nounderline abstract_t">Blaivas JG, Sandhu J. Urethral reconstruction after erosion of slings in women. Curr Opin Urol 2004; 14:335.</a></li><li><a class="nounderline abstract_t">Solomon ER, Jelovsek JE. Removing a misplaced retropubic midurethral sling from the urethra and bladder neck using ear, nose, and throat instruments. Obstet Gynecol 2015; 125:58.</a></li><li><a class="nounderline abstract_t">Anger JT, Litwin MS, Wang Q, et al. Complications of sling surgery among female Medicare beneficiaries. Obstet Gynecol 2007; 109:707.</a></li><li><a class="nounderline abstract_t">Berger AA, Tan-Kim J, Menefee SA. The impact of midurethral sling surgery on the development of urinary tract infections. Int Urogynecol J 2022; 33:829.</a></li><li><a class="nounderline abstract_t">Klutke C, Siegel S, Carlin B, et al. Urinary retention after tension-free vaginal tape procedure: incidence and treatment. Urology 2001; 58:697.</a></li><li><a class="nounderline abstract_t">Norton PA, Nager CW, Chai TC, et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology 2013; 82:1038.</a></li><li><a class="nounderline abstract_t">Wheeler TL 2nd, Richter HE, Greer WJ, et al. Predictors of success with postoperative voiding trials after a mid urethral sling procedure. J Urol 2008; 179:600.</a></li><li><a class="nounderline abstract_t">Hong B, Park S, Kim HS, Choo MS. Factors predictive of urinary retention after a tension-free vaginal tape procedure for female stress urinary incontinence. J Urol 2003; 170:852.</a></li><li><a class="nounderline abstract_t">Nilsson CG, Kuuva N, Falconer C, et al. Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12 Suppl 2:S5.</a></li><li><a class="nounderline abstract_t">Barber MD, Gustilo-Ashby AM, Chen CC, et al. Perioperative complications and adverse events of the MONARC transobturator tape, compared with the tension-free vaginal tape. Am J Obstet Gynecol 2006; 195:1820.</a></li><li><a class="nounderline abstract_t">Brennand EA, Tang S, Birch C, et al. Early voiding dysfunction after midurethral sling surgery: comparison of two management approaches. Int Urogynecol J 2017; 28:1515.</a></li><li><a class="nounderline abstract_t">Jonsson Funk M, Siddiqui NY, Pate V, et al. Sling revision/removal for mesh erosion and urinary retention: long-term risk and predictors. Am J Obstet Gynecol 2013; 208:73.e1.</a></li><li><a class="nounderline abstract_t">Berger AA, Tan-Kim J, Menefee SA. Long-term Risk of Reoperation After Synthetic Mesh Midurethral Sling Surgery for Stress Urinary Incontinence. Obstet Gynecol 2019; 134:1047.</a></li><li><a class="nounderline abstract_t">Rardin CR, Rosenblatt PL, Kohli N, et al. Release of tension-free vaginal tape for the treatment of refractory postoperative voiding dysfunction. Obstet Gynecol 2002; 100:898.</a></li><li><a class="nounderline abstract_t">Laurikainen E, Kiilholma P. A nationwide analysis of transvaginal tape release for urinary retention after tension-free vaginal tape procedure. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:111.</a></li><li><a class="nounderline abstract_t">Lim JL, de Cuyper EM, Cornish A, Frazer M. Short-term clinical and quality-of-life outcomes in women treated by the TVT-Secur procedure. Aust N Z J Obstet Gynaecol 2010; 50:168.</a></li><li><a class="nounderline abstract_t">Jeffry L, Deval B, Birsan A, et al. Objective and subjective cure rates after tension-free vaginal tape for treatment of urinary incontinence. Urology 2001; 58:702.</a></li><li><a class="nounderline abstract_t">Wu E, High R, Lewis C, et al. Retropubic mid-urethral slings and de novo urinary urgency and frequency: The role of retropubic hematomas. Neurourol Urodyn 2021; 40:1686.</a></li><li><a class="nounderline abstract_t">Agostini A, Bretelle F, Franchi F, et al. Immediate complications of tension-free vaginal tape (TVT): results of a French survey. Eur J Obstet Gynecol Reprod Biol 2006; 124:237.</a></li><li><a class="nounderline abstract_t">Estevez JP, Cosson M, Boukerrou M. An uncommon case of urethrovaginal fistula resulting from tension-free vaginal tape. Int Urogynecol J 2010; 21:889.</a></li><li><a class="nounderline abstract_t">Jasaitis Y, Sergent F, Tanneau Y, Marpeau L. [Vesicovaginal fistula after transobturator tape]. Prog Urol 2007; 17:253.</a></li><li><a class="nounderline abstract_t">Kobashi KC, Govier FE. Perioperative complications: the first 140 polypropylene pubovaginal slings. J Urol 2003; 170:1918.</a></li><li><a class="nounderline abstract_t">Walters MD, Tulikangas PK, LaSala C, Muir TW. Vascular injury during tension-free vaginal tape procedure for stress urinary incontinence. Obstet Gynecol 2001; 98:957.</a></li><li><a class="nounderline abstract_t">Zorn KC, Daigle S, Belzile F, Tu le M. Embolization of a massive retropubic hemorrhage following a tension-free vaginal tape (TVT) procedure: case report and literature review. Can J Urol 2005; 12:2560.</a></li><li><a class="nounderline abstract_t">Flock F, Reich A, Muche R, et al. Hemorrhagic complications associated with tension-free vaginal tape procedure. Obstet Gynecol 2004; 104:989.</a></li><li><a class="nounderline abstract_t">Balachandran A, Curtiss N, Duckett J. The management of massive haematomas after insertion of retropubic mid-urethral slings. Int Urogynecol J 2015; 26:1449.</a></li><li><a class="nounderline abstract_t">Huffaker RK, Yandell PM, Shull BL. Tension-free vaginal tape bowel perforation. Int Urogynecol J 2010; 21:251.</a></li><li><a class="nounderline abstract_t">Fourie T, Cohen PL. Delayed bowel erosion by tension-free vaginal tape (TVT). Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:362.</a></li><li><a class="nounderline abstract_t">Huang X, Jiang H, Xie L. Case report of sigmoid colon perforation and colocutaneous fistula due to retropubic midurethral sling placement for stress urinary incontinence. BMC Urol 2020; 20:33.</a></li><li><a class="nounderline abstract_t">Mayhew AC, Ford AT, Northington GM, et al. Delayed Presentation of Cecal Perforation With Tension-Free Vaginal Tape. Obstet Gynecol 2018; 131:499.</a></li><li><a class="nounderline abstract_t">Nygaard IE, Heit M. Stress urinary incontinence. Obstet Gynecol 2004; 104:607.</a></li><li><a class="nounderline abstract_t">Leboeuf L, Tellez CA, Ead D, Gousse AE. Complication of bowel perforation during insertion of tension-free vaginal tape. J Urol 2003; 170:1310; discussion 1310.</a></li><li><a class="nounderline abstract_t">Meschia M, Busacca M, Pifarotti P, De Marinis S. Bowel perforation during insertion of tension-free vaginal tape (TVT). Int Urogynecol J Pelvic Floor Dysfunct 2002; 13:263.</a></li><li><a class="nounderline abstract_t">Castillo OA, Bodden E, Olivares RA, Urena RD. Intestinal perforation: an infrequent complication during insertion of tension-free vaginal tape. J Urol 2004; 172:1364.</a></li><li><a class="nounderline abstract_t">Daneshgari F, Kong W, Swartz M. Complications of mid urethral slings: important outcomes for future clinical trials. J Urol 2008; 180:1890.</a></li><li><a class="nounderline abstract_t">Rooney KE, Cholhan HJ. Bowel perforation during retropubic sling procedure. Obstet Gynecol 2010; 115:429.</a></li><li><a class="nounderline abstract_t">Kobashi KC, Govier FE. Management of vaginal erosion of polypropylene mesh slings. J Urol 2003; 169:2242.</a></li><li><a class="nounderline abstract_t">Mesens T, Aich A, Bhal PS. Late erosions of mid-urethral tapes for stress urinary incontinence--need for long-term follow-up? Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:1113.</a></li><li><a class="nounderline abstract_t">Wijffels SA, Elzevier HW, Lycklama a Nijeholt AA. Transurethral mesh resection after urethral erosion of tension-free vaginal tape: report of three cases and review of literature. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:261.</a></li><li><a class="nounderline abstract_t">Gurol-Urganci I, Geary RS, Mamza JB, et al. Long-term Rate of Mesh Sling Removal Following Midurethral Mesh Sling Insertion Among Women With Stress Urinary Incontinence. JAMA 2018; 320:1659.</a></li><li><a class="nounderline abstract_t">Rehman J, Chugtai B, Sukkarich T, Khan SA. Extraperitoneal laparoscopic removal of eroded midurethral sling: a new technique. J Endourol 2008; 22:365.</a></li><li><a class="nounderline abstract_t">Rigaud J, Pothin P, Labat JJ, et al. Functional results after tape removal for chronic pelvic pain following tension-free vaginal tape or transobturator tape. J Urol 2010; 184:610.</a></li><li><a class="nounderline abstract_t">Johnson DW, ElHajj M, OBrien-Best EL, et al. Necrotizing fasciitis after tension-free vaginal tape (TVT) placement. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:291.</a></li><li><a class="nounderline abstract_t">Geis K, Dietl J. Ilioinguinal nerve entrapment after tension-free vaginal tape (TVT) procedure. Int Urogynecol J Pelvic Floor Dysfunct 2002; 13:136.</a></li><li><a class="nounderline abstract_t">Vervest HA, Bongers MY, van der Wurff AA. Nerve injury: an exceptional cause of pain after TVT. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:665.</a></li><li><a class="nounderline abstract_t">Ramanathan A, Bryant S, Montoya TI, Wai CY. Obturator neuropathy after retropubic tension-free vaginal tape placement. Obstet Gynecol 2015; 125:62.</a></li><li><a class="nounderline abstract_t">Bogusiewicz M, Monist M, Stankiewicz A, et al. Most of the patients with suburethral sling failure have tapes located outside the high-pressure zone of the urethra. Ginekol Pol 2013; 84:334.</a></li><li><a class="nounderline abstract_t">Staack A, Vitale J, Ragavendra N, Rodríguez LV. Translabial ultrasonography for evaluation of synthetic mesh in the vagina. Urology 2014; 83:68.</a></li><li><a class="nounderline abstract_t">Hegde A, Nogueiras GM, Aguilar V, Davila G. Dynamic assessment of sling function on transperineal ultrasound: Is it correlated with outcomes one year following surgery (abstract)? Female Pelvic Med Reconstr Surg 2013; 19:S57.</a></li><li><a class="nounderline abstract_t">Smithling KR, Adams-Piper EE, Tran AM, et al. Efficacy of Repeat Midurethral Sling for Persistent or Recurrent Stress Urinary Incontinence: A Fellows Pelvic Research Network Study. Female Pelvic Med Reconstr Surg 2019; 25:430.</a></li><li><a class="nounderline abstract_t">Melnikoff AK, Meyer I, Martin KD, Richter HE. Incontinence outcomes after "second primary" compared to repeat midurethral sling for recurrent and persistent stress urinary incontinence. Int Urogynecol J 2021; 32:75.</a></li><li><a class="nounderline abstract_t">Bergman I, Westergren Söderberg M, Lundqvist A, Ek M. Associations Between Childbirth and Urinary Incontinence After Midurethral Sling Surgery. Obstet Gynecol 2018; 131:297.</a></li><li><a class="nounderline abstract_t">Dyrkorn OA, Staff AC, Kulseng-Hanssen S, et al. Childbirth after mid-urethral sling surgery: effects on long-term success and complications. Int Urogynecol J 2020; 31:485.</a></li><li><a class="nounderline abstract_t">Nahshon C, Abramov Y, Kugelman N, et al. The effect of subsequent pregnancy and childbirth on stress urinary incontinence recurrence following midurethral sling procedure: a meta-analysis. Am J Obstet Gynecol 2023.</a></li><li><a class="nounderline abstract_t">Tulokas SA, Rahkola-Soisalo P, Gissler M, et al. Pregnancy and delivery after mid-urethral sling operation. Int Urogynecol J 2021; 32:179.</a></li><li><a class="nounderline abstract_t">Groenen R, Vos MC, Willekes C, Vervest HA. Pregnancy and delivery after mid-urethral sling procedures for stress urinary incontinence: case reports and a review of literature. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:441.</a></li><li><a class="nounderline abstract_t">Panel L, Triopon G, Courtieu C, et al. How to advise a woman who wants to get pregnant after a sub-urethral tape placement? Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:347.</a></li><li><a class="nounderline abstract_t">Dainer M, Hall CD, Choe J, Bhatia N. Pregnancy following incontinence surgery. Int Urogynecol J Pelvic Floor Dysfunct 1998; 9:385.</a></li><li><a class="nounderline abstract_t">Kohorst F, Flock F, Kreienberg R, Reich A. Pregnancy and delivery after tension-free vaginal tape (TVT) procedure: literature review and case report. Eur J Obstet Gynecol Reprod Biol 2010; 151:10.</a></li><li><a class="nounderline abstract_t">Davis TL, Lukacz ES, Luber KM, Nager CW. Determinants of patient satisfaction after the tension-free vaginal tape procedure. Am J Obstet Gynecol 2004; 191:176.</a></li><li><a class="nounderline abstract_t">Nilsson CG, Palva K, Aarnio R, et al. Seventeen years' follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J 2013; 24:1265.</a></li><li><a class="nounderline abstract_t">Richter HE, Litman HJ, Lukacz ES, et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstet Gynecol 2011; 117:913.</a></li></ol></div><div id="topicVersionRevision">Topic 14217 Version 40.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12559262" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19941278" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16985863" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The definition, prevalence, and risk factors for stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22669423" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Population-based trends in ambulatory surgery for urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34161707" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Stress Incontinence in Women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8798092" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32079836" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Joint Report on Terminology for Surgical Procedures to Treat Stress Urinary Incontinence in Women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14677000" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : How does tension-free vaginal tape correct stress incontinence? investigation by perineal ultrasound.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15027016" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The 'iris effect': how two-dimensional and three-dimensional ultrasound can help us understand anti-incontinence procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33206433" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Ultrasound imaging of slings and meshes in urogynecology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17001442" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Strength of tissue attachment to mesh after ventral hernia repair with synthetic composite mesh in a porcine model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34003308" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Impact of intrinsic sphincter deficiency on mid-urethral sling outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21683412" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Baseline urodynamic predictors of treatment failure 1 year after mid urethral sling surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26220506" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Retropubic or transobturator mid-urethral slings for intrinsic sphincter deficiency-related stress urinary incontinence in women: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19304370" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Tension-free vaginal tape in the management of recurrent urodynamic stress incontinence after previous failed midurethral tape.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18542836" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Long-term efficacy of tension-free vaginal tape in the management of stress urinary incontinence in women: efficacy at 5- and 7-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11450973" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Tension-Free vaginal tape (TVT) in stress incontinent women with intrinsic sphincter deficiency (ISD)--a long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11458067" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The tension-free vaginal tape procedure in women with previous failed stress incontinence surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19641837" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Small bowel perforation in a hernia sac after TVT placement at the time of colpocleisis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20643439" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Pelvic organ prolapse management in female kidney transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19756342" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : TVT or TOT? When to avoid retropubic trocar passage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26130017" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Mid-urethral sling operations for stress urinary incontinence in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18313452" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The expectations of patients who undergo surgery for stress incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18250947" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Outcome measures after TVT for mixed urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18001792" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The impact of tension-free vaginal tape on overactive bladder symptoms in women with stress urinary incontinence: significance of detrusor overactivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32947550" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Treat or Wait? Natural Perioperative Course of Overactive Bladder Symptoms at the Time of Midurethral Sling Placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31529007" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery vs Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15965577" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Bladder wall abscess following midurethral sling procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20856653" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Bilateral recurrent thigh abscesses for five years after a transobturator tape implantation for stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17577593" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Adductor brevis myositis following transobturator tape procedure: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15572489" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Necrotizing surgical site infection after tension-free vaginal tape.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16868660" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Perineal cellulitis and persistent vaginal erosion after transobturator tape (Obtape)--case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16721496" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Severe soft tissue infection of the thigh after vaginal erosion of transobturator tape for stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29794678" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : ACOG Practice Bulletin No. 195: Prevention of Infection After Gynecologic Procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29794678" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : ACOG Practice Bulletin No. 195: Prevention of Infection After Gynecologic Procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9795826" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20479459" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Retropubic versus transobturator midurethral slings for stress incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15580418" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Tension free vaginal tape: is the intra-operative cough test necessary?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12121726" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The efficacy and safety of the tension-free vaginal tape procedure do not depend on the method of analgesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17549428" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The effect of spinal anaesthesia on urethral function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18188491" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : The effect of local anaesthetic infiltration on urethral function during the tension-free vaginal tape (TVT) procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18259908" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Predicting early voiding dysfunction after tension-free vaginal tape.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16389011" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : What determines a successful tension-free vaginal tape? A prospective multicenter cohort study: results from The Netherlands TVT database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12738153" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The relationship of tension-free vaginal tape insertion and the vascular anatomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16260518" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Bladder perforation during tension-free vaginal tape procedures: analysis of learning curve and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25730214" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Sodium fluorescein use during intraoperative cystoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32769657" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Two Intraoperative Techniques for Midurethral Sling Tensioning: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17572190" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Management of vaginal extrusion after tension-free vaginal tape procedure for urodynamic stress incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26894607" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Incidence of successful voiding and predictors of early voiding dysfunction after retropubic sling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27319367" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Predictors of early postoperative voiding dysfunction and other complications following a midurethral sling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20727543" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Comparison of 2 techniques to predict voiding efficiency after inpatient urogynecologic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18060956" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : A randomized, controlled trial evaluating 2 techniques of postoperative bladder testing after transvaginal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23983149" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Repeat post-op voiding trials: an inconvenient correlate with success.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32617636" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Complications and re-operations after tension-free vaginal tape operation in women with stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17847759" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Bladder perforation during tension-free vaginal tape surgery: does it matter?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20577714" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Complications of the tension-free vaginal tape procedure for stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15217442" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Complications of tension-free vaginal tape surgery: a multi-institutional review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20559618" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : TVT compared with TVT-O and TOT: results from the Norwegian National Incontinence Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21925636" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14995927" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : The techniques of trocar insertion and intraoperative urethrocystoscopy in tension-free vaginal taping: an experience of 600 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12066948" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Short term complications of the tension free vaginal tape operation for stress urinary incontinence in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23417312" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Expectant management of cystotomy at the time of midurethral sling placement: a retrospective case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12052601" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Recognition of occult bladder injury during the tension-free vaginal tape procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17149713" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Presentation and management of major complications of midurethral slings: Are complications under-reported?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17310310" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Bladder erosion of tension-free vaginal tape presented as vesical stone; management and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19591616" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Transurethral resection of intravesical mesh after midurethral sling procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18485041" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : A safe and simple solution for intravesical tension-free vaginal tape erosion: removal by standard transurethral resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19438488" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Urethral injury associated with minimally invasive mid-urethral sling procedures for the treatment of stress urinary incontinence: a case series and systematic literature search.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12738152" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Complications and untoward effects of the tension-free vaginal tape procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12745732" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Urethral erosion of tension-free vaginal tape.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16741603" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Delayed urethral erosion after tension-free vaginal tape.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15626875" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Urethral reconstruction after erosion of slings in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25560104" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Removing a misplaced retropubic midurethral sling from the urethra and bladder neck using ear, nose, and throat instruments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17329524" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Complications of sling surgery among female Medicare beneficiaries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33797594" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : The impact of midurethral sling surgery on the development of urinary tract infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11711343" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Urinary retention after tension-free vaginal tape procedure: incidence and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24358480" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Risk factors for incomplete bladder emptying after midurethral sling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18082219" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Predictors of success with postoperative voiding trials after a mid urethral sling procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12913715" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Factors predictive of urinary retention after a tension-free vaginal tape procedure for female stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11450979" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17027591" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Perioperative complications and adverse events of the MONARC transobturator tape, compared with the tension-free vaginal tape.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28285398" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Early voiding dysfunction after midurethral sling surgery: comparison of two management approaches.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23099189" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Sling revision/removal for mesh erosion and urinary retention: long-term risk and predictors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31599825" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Long-term Risk of Reoperation After Synthetic Mesh Midurethral Sling Surgery for Stress Urinary Incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12423850" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Release of tension-free vaginal tape for the treatment of refractory postoperative voiding dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16132161" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : A nationwide analysis of transvaginal tape release for urinary retention after tension-free vaginal tape procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20522075" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Short-term clinical and quality-of-life outcomes in women treated by the TVT-Secur procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11711344" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Objective and subjective cure rates after tension-free vaginal tape for treatment of urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34196027" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Retropubic mid-urethral slings and de novo urinary urgency and frequency: The role of retropubic hematomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16095800" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Immediate complications of tension-free vaginal tape (TVT): results of a French survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20052572" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : An uncommon case of urethrovaginal fistula resulting from tension-free vaginal tape.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17489330" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : [Vesicovaginal fistula after transobturator tape].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14532807" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Perioperative complications: the first 140 polypropylene pubovaginal slings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11704220" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Vascular injury during tension-free vaginal tape procedure for stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15777497" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Embolization of a massive retropubic hemorrhage following a tension-free vaginal tape (TVT) procedure: case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15516389" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Hemorrhagic complications associated with tension-free vaginal tape procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25510464" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : The management of massive haematomas after insertion of retropubic mid-urethral slings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19597717" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Tension-free vaginal tape bowel perforation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14618319" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Delayed bowel erosion by tension-free vaginal tape (TVT).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32197605" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Case report of sigmoid colon perforation and colocutaneous fistula due to retropubic midurethral sling placement for stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29420415" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Delayed Presentation of Cecal Perforation With Tension-Free Vaginal Tape.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15339776" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14501754" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Complication of bowel perforation during insertion of tension-free vaginal tape.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12189433" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Bowel perforation during insertion of tension-free vaginal tape (TVT).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15371844" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Intestinal perforation: an infrequent complication during insertion of tension-free vaginal tape.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18801499" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Complications of mid urethral slings: important outcomes for future clinical trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20093869" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Bowel perforation during retropubic sling procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12771759" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Management of vaginal erosion of polypropylene mesh slings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17347793" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Late erosions of mid-urethral tapes for stress urinary incontinence--need for long-term follow-up?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18716705" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Transurethral mesh resection after urethral erosion of tension-free vaginal tape: report of three cases and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30357298" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Long-term Rate of Mesh Sling Removal Following Midurethral Mesh Sling Insertion Among Women With Stress Urinary Incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18294043" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Extraperitoneal laparoscopic removal of eroded midurethral sling: a new technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20639025" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Functional results after tape removal for chronic pelvic pain following tension-free vaginal tape or transobturator tape.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14530844" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Necrotizing fasciitis after tension-free vaginal tape (TVT) placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12054182" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Ilioinguinal nerve entrapment after tension-free vaginal tape (TVT) procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16633884" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Nerve injury: an exceptional cause of pain after TVT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25560105" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Obturator neuropathy after retropubic tension-free vaginal tape placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23819397" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Most of the patients with suburethral sling failure have tapes located outside the high-pressure zone of the urethra.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24231215" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Translabial ultrasonography for evaluation of synthetic mesh in the vagina.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Dynamic assessment of sling function on transperineal ultrasound: Is it correlated with outcomes one year following surgery (abstract)?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30694873" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Efficacy of Repeat Midurethral Sling for Persistent or Recurrent Stress Urinary Incontinence: A Fellows Pelvic Research Network Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32712696" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Incontinence outcomes after "second primary" compared to repeat midurethral sling for recurrent and persistent stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29324615" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Associations Between Childbirth and Urinary Incontinence After Midurethral Sling Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31410519" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Childbirth after mid-urethral sling surgery: effects on long-term success and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/38036163" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : The effect of subsequent pregnancy and childbirth on stress urinary incontinence recurrence following midurethral sling procedure: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32840660" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Pregnancy and delivery after mid-urethral sling operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18071619" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Pregnancy and delivery after mid-urethral sling procedures for stress urinary incontinence: case reports and a review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17717624" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : How to advise a woman who wants to get pregnant after a sub-urethral tape placement?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9891960" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Pregnancy following incontinence surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20434826" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Pregnancy and delivery after tension-free vaginal tape (TVT) procedure: literature review and case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15295361" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Determinants of patient satisfaction after the tension-free vaginal tape procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23563892" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Seventeen years' follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21422865" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Demographic and clinical predictors of treatment failure one year after midurethral sling surgery.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
